ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0001038.1|Pyralomicin_1 # 1 # 690 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.726	BGC0001038.1|Pyralomicin_1 	1	690	-	Loose	1300	110.153	optrA	29.41	3003746	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGGACCGGCTGACGTACGTGCTGCCGGACGGGCGGCTGCTCCTGCACGAGGTGTCGTTCCGTGTCGGTGACGGAGCGAAGGCCGGGTTGGTCGGGCCGAACGGCGCGGGCAAGACCACCCTGCTGCGGCTGATCGCCGGCGATGTGCAGCCGGACGACGGCCGCGTCGTCTCCTCCGGCGGGCTGGGCGTGATGCGGCAGTTCATCGGCAGCATCCGTGACGACCGCAGCGTGCACGACCTGCTGCTGTCGGTGGCCCCCGACCGCGTCCGCGCCGCCGCCTCGGCCCTGGTCCGGGCCGAGGCGGCGATGGCGGCCCGCGACGACGAGGCGGCCCAGCTCGCCTACGCCCAGGCCGCCGCCGACTATGCCGACGTCGGCGGCTACGACATGGAGGTGGTCTGGGACGTCTGCGCCACCGAGGCCATGGGCCTGTCCTACGACGAGGTCAAGGACCGTCCGGTCACCACACTGTCGGGCGGGGAGCAGAAGCGCATCGTCCTGGAGGCGCTGCTGCGCGGCCCGGACGAGGTCCTGCTGCTGGACGAGCCGGACAACTACCTCGACGTGGCCGGCAAGCTGTGGCTGGAGAGCCGGTTGCAGGCCACGCCCAAGACCGTGCTGCTGGTCTCGCACGACCGCCAGCTCCTGGCCAACGCCGCCGACCGGATCGTCACCGTGGAGGACCGC	MDRLTYVLPDGRLLLHEVSFRVGDGAKAGLVGPNGAGKTTLLRLIAGDVQPDDGRVVSSGGLGVMRQFIGSIRDDRSVHDLLLSVAPDRVRAAASALVRAEAAMAARDDEAAQLAYAQAAADYADVGGYDMEVVWDVCATEAMGLSYDEVKDRPVTTLSGGEQKRIVLEALLRGPDEVLLLDEPDNYLDVAGKLWLESRLQATPKTVLLVSHDRQLLANAADRIVTVEDR	MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM	35.11	gnl|BL_ORD_ID|2118|hsp_num:0	2263		
BGC0001038.1|Pyralomicin_2 # 697 # 1515 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.686	BGC0001038.1|Pyralomicin_2 	697	1515	+	Loose	400	64.6994	tetR	31.73	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCCGCCACAACTGGCCCTTCTTGCGCTCGTCACTCTCTGGACCGATGGTCCAGTACAGGATCAGCGATCTGGAGTCTTGTCGTCATATTAGACTTCCGTCCGTGGATATGAGCAAGGCGGGACCGACGACAGGAGGCGCTGGGGGCGTATGGCTGCGGCCGGCCACTCGACCGGGGCGCGAAGGGCCGCCGCTCACCCGCGAGCGGATCATCGCCGAGGCGCTGGCCCTGCTCGACGAGGAGGGCGTCGACCGGCTGACCATGCGCCGGCTCGCCCAGCGGCTCGGCACCGGCTCCACCACCCTGTACTGGCACGTCAAGACCAAGGACGACGTGCTGGACCTGACGCTCGACATGATCTTCGGGGAGATCGAGATCCCCGCGCGGGACAACGGCGACTGGCGCGGCGCCGTCATCACGCTTGCCAACCGGTGGCGTGCGGTGCTGCTCAAGCACCCCTGGTCGGCGGTGCTGCTGGGCCGCCCCATGCTCGGCCCGAACGTGCTCACCCGCAGCGAGTTCCTGTACTCCACCCTGGTCAAGGCCGGTGTCACCGAACCCCACCTCACCGGCGCCGCCTACAGCCTGTCCAACTACATCATCGGATCGGCACTGATGCAGGCCACCTGGTCCACCAACGCCGAGCCGGGCGTGCGGCAGGCCGCTGGCGAGCACCTGCGTGCCAACCAGGACAGCTACCCGATTCTCGCCACTCACGGCCCCCTGGTCGCCGGTGACGACTGGGACACCGGCTTCGGCTTCGGCCTCACCTGGCTGCTCGACGGCATCGCGAAGGTCGCCGGCGCCGGCGCGTGA	MSRHNWPFLRSSLSGPMVQYRISDLESCRHIRLPSVDMSKAGPTTGGAGGVWLRPATRPGREGPPLTRERIIAEALALLDEEGVDRLTMRRLAQRLGTGSTTLYWHVKTKDDVLDLTLDMIFGEIEIPARDNGDWRGAVITLANRWRAVLLKHPWSAVLLGRPMLGPNVLTRSEFLYSTLVKAGVTEPHLTGAAYSLSNYIIGSALMQATWSTNAEPGVRQAAGEHLRANQDSYPILATHGPLVAGDDWDTGFGFGLTWLLDGIAKVAGAGA	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	130.77	gnl|BL_ORD_ID|455|hsp_num:0	276		
BGC0001038.1|Pyralomicin_3 # 1529 # 2368 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0001038.1|Pyralomicin_3 	1529	2368	-	Loose	400	32.7278	vanRA	26.09	3002919	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGAATATCGTGCCGACTGCTGGAAAACCGAGACAGATATTCGCGGTGCTGGCGCTGAACGCGAACAATATCGTGCCCGTTCGCGTGCTCATCGAGGAGGTGTGGGGCGAACGCCCGCCGCGCAGTGCCGGCACCACCTTGCAGACCTACGTCCTCCAACTGCGCAAACGGCTGGCCGTCGCGCTGGGCCGGAACGCGTCCCGCAGCCCGAAGGATCTGCTCGTCACCGCCAACGGCGGTTATCTCCTCTCGGTGCCGGCCGGATCGCGCGACATCGAGGACTTCGACCGCCTGACGGGGCGGGCCAGGCGCGCCGGCGATCCGGCCGAGGCTTTCCGGCTGTTCAACCAGGCGCTGGCGCTGTGGCGCGGATCGACCCTGGTGGACGTCCCGATCGGCCACACGCTCGAACGCGAGGTGGTCCGCCTGGAGGAGACCAGGACCAAGACGCTGCACGAACGCAACGAGATCGGGCTGCAACTCGGGCTGCACGCCGAACTGCTCGGCGAGCTGGCCGCGCTGAGCCGGAGCAACCCGATGGACGAGACCATCCAGGGACACTTCATCGTGGCCCTGTACCGGATGGGGCGCACGCTCGACGCGCTGGAGACCTACCAGCGCCTGCGCCGGACCATGGTCGAGGAACTGGGCCTGGAACCGTCGGACCGGCTGCGCGAGTTGCAGCGGGCCGTGCTCGCCTCCTCCCCGGAGCTGGACGTCCCGGCGGCCAGGCGGCGGCGGTTGGGGGCGGCCTCGCGCCAGGAGTGCCCGATGTGCGGCGGCAACTTCATCCGCGGCTGGCGGGCCCGTCAGGAGTTGATGGTCCCGCGCGTGTCGTGA	MNIVPTAGKPRQIFAVLALNANNIVPVRVLIEEVWGERPPRSAGTTLQTYVLQLRKRLAVALGRNASRSPKDLLVTANGGYLLSVPAGSRDIEDFDRLTGRARRAGDPAEAFRLFNQALALWRGSTLVDVPIGHTLEREVVRLEETRTKTLHERNEIGLQLGLHAELLGELAALSRSNPMDETIQGHFIVALYRMGRTLDALETYQRLRRTMVEELGLEPSDRLRELQRAVLASSPELDVPAARRRRLGAASRQECPMCGGNFIRGWRARQELMVPRVS	MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTSGLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRYKKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSELLFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK	120.78	gnl|BL_ORD_ID|680|hsp_num:0	722		
BGC0001038.1|Pyralomicin_4 # 2536 # 3384 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.776	BGC0001038.1|Pyralomicin_4 	2536	3384	-	Loose	550	24.6386	LRA-2	28.57	3002485	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	GTGAACGGGCAGGGGCCTCTCGTGGGCCTCGCGGAATGGCGGCTGCCCTGCTCGGGCGAGCAGGCGCTGCGGCTGGCGGCGCGGGTCGGCGCCGAGGGGGTGCAGCTGGAGTTCGGCGGCCCCGGCCGGGGCGGGTGGGCCGACGCGCCGGGACGGGTCGGCGCGCTGCTGGAGACGTCGTCGGCGACCGGCGTCGCCCTCCTGGCCGTGGCCGGCAACGTGCTCAACGACCTGGGCCTGGCCGCATCGCCCGGAGGCCGGACCGAGTCACGGGTGCGGCGCGTGCTGGTCCGCCTGCTCGACACCGCGCGGGAGCTGCACGTCCCGCTGGTCCTGGTGCCGAGCTTCCGCCGCAGCGCCATCGACGGACCGAGGGCGTTCGCGCGCACGGCGCGCTTGCTGGCCTGGGCCGCTGCCGAGGCGGGCGCCCGCGGCCTGCTGCTGGCCAGCGAGAACGTGCTGGCCGACGAGGACGCCCGGGCACTGGTGGAGCAGGTCGCCTCCCAGGCCTTCCGCCTCGCCCTGGACACCTACAACCCGGTCACCGTCGGCCTCGACGCGGCACAGCTGGTCAAGGCGCTGGGCCCGGCACTCGCCGACCAGGTGCACCTCAAGGACGGCCCGCCGGCCGTGGGTGACATGCCCGCCCTCGGCATGGGGACGGCGCGGCTGGAGGAGACGCTCGCCGCGCTGGGCGCGCAGCGGCACCCCGTCCGGGCGCTCGTCCTCGAGAACGACTACCGCGACGGCCGCGCCGGCCGGATCGCCGCGGACCTCGCCTGGGCGCGCGCCGCGGCCGACCGCCACCGGCTGGCGACAGCGGATCAGACCCGCGGAACGGGCCCGTGA	MNGQGPLVGLAEWRLPCSGEQALRLAARVGAEGVQLEFGGPGRGGWADAPGRVGALLETSSATGVALLAVAGNVLNDLGLAASPGGRTESRVRRVLVRLLDTARELHVPLVLVPSFRRSAIDGPRAFARTARLLAWAAAEAGARGLLLASENVLADEDARALVEQVASQAFRLALDTYNPVTVGLDAAQLVKALGPALADQVHLKDGPPAVGDMPALGMGTARLEETLAALGAQRHPVRALVLENDYRDGRAGRIAADLAWARAAADRHRLATADQTRGTGP	MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYFVGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGGVAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGALRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASSFSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLASEG	93.38	gnl|BL_ORD_ID|1247|hsp_num:0	1324		
BGC0001038.1|Pyralomicin_5 # 3381 # 4202 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.753	BGC0001038.1|Pyralomicin_5 	3381	4202	-	Loose	500	25.7942	ANT(4')-Ia	26.92	3002623	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGATAGCTGACCGTGCGGAACCGCTGCGCGGACGGCGGGCCCTCGTCGTCGGCGGATCCACCGGCATCGGCCGGGCGATCGCCCAGGCCTGGTCCGACGCCGGCGCGCAGGTGGTCGTCTGCAGCCGCACCGAGCCCCGCGACGTGGCGTGGGAGTGGTGCCAGGTGGACCTGGCCGACCCGGGACAGGCCCGGGAACGCCTGAACAGGCTCGGCTCCGGCCGGCTCGACATGGTGTGCTTCTCGGCCGTCCACTACGGCGAGCGGCGGGCCAGGTTCTGCGACACCGCCGAGGCCGAGTGGCGCCACCAGCTCGAGGTGAACGTCACCGGGCTCTGGCTCACCCTGGCCGCCACCCTGCCCGCGCTCCGCGCCGCGGCGCCCGGCCTGATGGTGGGGGTCTCCTCGGAGGTCGCGTTCAACGCGGGGCCGGAACGCAGCGGCTACGCCGCGACGAAGGCGGCGGCCAAGGCGTTGCTTGATTCGCTGGCGCAGGAGGAGGACCCCGCCGAGGTGCGGATCGTGCAGGTGCTGCCCGCGGAGATGGTCGACACGCCCGGCATCCGCAGACGGCGCGCGCCCGGCTTCGACTACGGCTCCTACATGCGGCCGGCCGCCTTCGCCCGGCTCGCCGTGGCGCTGAGCACCGCGCCGGGACCCGAATATCACGGCGAGAGCCTGGTGGTGGGCGAGGACGGCACCTGGTGGCCGGCCCACGCCCGAACACCCCGCTCCCAGAGCCGCCCCACGCCCCAGCCCACCCCCCGAAGCGCCCCCACCCCCTCCCGGCCCACGCCACCGAGCCGCCGGGGGCGGTCGTGA	MIADRAEPLRGRRALVVGGSTGIGRAIAQAWSDAGAQVVVCSRTEPRDVAWEWCQVDLADPGQARERLNRLGSGRLDMVCFSAVHYGERRARFCDTAEAEWRHQLEVNVTGLWLTLAATLPALRAAAPGLMVGVSSEVAFNAGPERSGYAATKAAAKALLDSLAQEEDPAEVRIVQVLPAEMVDTPGIRRRRAPGFDYGSYMRPAAFARLAVALSTAPGPEYHGESLVVGEDGTWWPAHARTPRSQSRPTPQPTPRSAPTPSRPTPPSRRGRS	MNMNGPASMAQKERLQTCQEIAKRLHEVYGNDVLAIGVYGSVSRGTDGPFSDIEMFCVLRDSAETVDKSYEWSAGPWKAEVNVCSASILLKDAATVEDRWPLTHGPYFSPLRLYDPEGFFQRLRLAAESPTKEDFRQAIHEILVGEMYEYVGKLRNVNRNGPSTYLPSLALRFAHYGAMLIGLHNQTLFSTGAMVLPEALKLPHRPKGFDHVAELAMSGDLAQPAKIVSACEDFWKGLVAWAAEHDYVIHSKRIPF	106.64	gnl|BL_ORD_ID|1637|hsp_num:0	1737		
BGC0001038.1|Pyralomicin_6 # 4192 # 5511 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.760	BGC0001038.1|Pyralomicin_6 	4192	5511	-	Loose	500	26.5646	Escherichia coli ampH beta-lactamase	28.68	3004612	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	ATGACGGCCCCGGACGACGCGGCCCTCGGGCACGACACGAGCGGCGGGCACGGCACGGGCGGCCGGGACAGCGCGACCGCCGGCCACCGGGCGACCGGCCGTGACTTTCTGATCGGCCGGCATCGTGCGATCGTCCGCTCGGGACGCTCGCTCGCCGTCGGCCTCCGGGTCACGGCCGAACCGGGGCCGGGCGAACTGAGCGTGGCTGTGGAGGTGGCGGGGCTGTGCGGCACCGACATCCAGATGCTGCGCGGCCTGCGCGACGACGGCGCGTGCGTCATCGGGCACGAGGGACTGGCCAGGGTCGTGCGGGCCGGTCCCGGCACGGACATCGAGCCGGGAACCCGGGTCCTGGTCAACCCGACCCATCCGCACGACCCGTCCTTCCTCCTCGGGCACAACGTGGACGGGCTCTTCCAGGAGCGGGTGCTCCTGCCGTCCGCGGCCGTGACGGGCGGGATGGTGCTCGCCGTGGGGGAGGACGAACTCCCCGAGCCGAAGCTCGCCGTCCTGGCCGAACCGCTGGCCGTCGTCCGCTACGCGCTGGAGACCCTGCGCCGCTTCACTCCAGGGACGCTGGTGGTCGTCGGGGACGGGACGGTCGGGCACCTGGCGGTGCGCGCCGCCCGCAGGTGGCTGGGCCCGGCGCGCGTCGTGCACGTGCATCACACGGCGGCCGGGCTTGCCTGGAGCAGGCAGGCCGCGAGCCCGGCCGACGCGCTGGTCCTCGCCGACGACCTCGGCCGCCCCGGAACGCCCGGTGGGTGGGCCGGCGACGATGCCGGCACGCGGGCGGGCGGCCGTGCCGGGGCCGGCAGGTGGACCCGTGCCGGGACCGGGGACGTGGTCGCCGTCCTGCTCGCCACCCCCCGCGACGCCACGGTCCCCATGCTGGACCGGGTGCTCGCCATGGGCGCGGGCACGGCGGTGGTGGACCTGGTGGGCGGGGTGCCGCCGGAGGCCCGCACGCCGCTGCTGCCCGGGGTCGACATGGCCGCCGTCCGGGCGGCGAACTGCGGCGGGATCCCCGCCGTGCCCGTCGTGCGCGAGACGGTCACCGGCGCCGGCCGCCGCGTCCTCCTGTTCGGGCACAGGGGCGTGGCCAACCGCCATCTCACCACGGCCGTCAGGGAACTGCGGGCCGTCCCCGGACGGTACCGCGAACTGCTGACCCACGAGAGCGACCTGGCCGGCGCCGTCCGGCACTTTCGGGCGCTCGCCGGATCCGCCGACCGCACGATCGACGGCGAACGCCTGATCAAGCTGGCCGTCCACGTCGGCGCCTCCGCACCCCAGGAAGGAAACGATCATGATAGCTGA	MTAPDDAALGHDTSGGHGTGGRDSATAGHRATGRDFLIGRHRAIVRSGRSLAVGLRVTAEPGPGELSVAVEVAGLCGTDIQMLRGLRDDGACVIGHEGLARVVRAGPGTDIEPGTRVLVNPTHPHDPSFLLGHNVDGLFQERVLLPSAAVTGGMVLAVGEDELPEPKLAVLAEPLAVVRYALETLRRFTPGTLVVVGDGTVGHLAVRAARRWLGPARVVHVHHTAAGLAWSRQAASPADALVLADDLGRPGTPGGWAGDDAGTRAGGRAGAGRWTRAGTGDVVAVLLATPRDATVPMLDRVLAMGAGTAVVDLVGGVPPEARTPLLPGVDMAAVRAANCGGIPAVPVVRETVTGAGRRVLLFGHRGVANRHLTTAVRELRAVPGRYRELLTHESDLAGAVRHFRALAGSADRTIDGERLIKLAVHVGASAPQEGNDHDS	MKRSLLFSAVLCAASLTSVHAAQPITEPEFASDIVDRYADHIFYGSGATGMALVVIDGNQRVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLNDPLSKYAPPGARVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLSTAKLKAAPGSQAAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCRRLMVAERGASPCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQRAQFTKVIGMDVPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFVVVTRSPLTRFKNMSDGINDLVTELSGNKPLVIPAS	114.03	gnl|BL_ORD_ID|2079|hsp_num:0	3307		
BGC0001038.1|Pyralomicin_7 # 5508 # 6521 # -1 # ID=1_7;partial=00;start_type=TTG;rbs_motif=AGGGGA;rbs_spacer=7bp;gc_cont=0.761	BGC0001038.1|Pyralomicin_7 	5508	6521	-	Loose	1200	25.7942	tet(44)	35.29	3000556	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	TTGTCGCAGTCGATCGCGGTCCTGGACGTGGGAGGCACGCACCTGCGCTGGGCCACGTGGAGCCGGCGGGGCGGGCTGGCCGCCGTCCGGCGGGTGGCCACACCCAGCCTGGCCAACGGAGCCGCGGAGCCGGTGGACGAGCTCCGAGCGCGCCTGGTCTCCGCCATGGCCCAGGCCGTGCCGGTGGACGGCGTGGCCGGCGTGGCCTTCGGCGCCGCCCTGGACCACCGCTCGGGAATCGTCTACGCCTCCGCCCCGCTGTGGGGCTCGTGCACCCGCCCCTTCGACCTGGCCGGCGCGCTGGCCCGGGCCAGGCCGGACGTCCGCTGGCACGTCGTCAACGACGTGACGGCGGCGCTGCTGCATCTGGCAGCCGGGCCGGTCGGCGCGAGCTGCCGCAAGCTGCTGCTCGTCACCGTCAGCACCGGGATCGCCGGCCGGACGCTCGACCGGCGCAGCGGCGAGATCCCGGTGGACGGCTGCGGCCTCCAGGGCGAGATCGGCCACCTGCCGGCCACCACCTCGATCGCCGGCCGGCCGGTCACGCTGGCCTGCGACTGCGGGCAACCGGACCACGTCTCCTCCTACTCCTCCGGGCCCGGTATCCGCCGGCTCGCCGCAGTCCTGCGGGAGCGGGACCCGGACGCCTGGCGCGGCAGCGCCCTCGACGGCCCGGGGCCGTTCGAGACGTTGCTGCCGGCCGCCCTCGACGCGGCTGACCCGGTGGCCGAAGAGCTGCTGCGGGCGGCGACGCGGCCCGTCGCGGACGTCGTCCGCTCCGCGCTGTGTCTCGACCCCGAGTTGGACGTCGTCGCGTTCACCGGTGGCGTCGTCCACGCGCTCGGCGCGCACTACCGCCGGGCGCTGCTGGCGCACCTGAACGCCCAGGGGATCTATCTCACCAGCGCGCTCGCCCCGGAGTCGATCACGGAGCGGTTGCTCGTGTGCCGTGAGGGAGAGGCCGATCCGCTGGTCGGCGCGGGCCTCGCCGCCGAGCGGACGGCCCGCTCATGA	MSQSIAVLDVGGTHLRWATWSRRGGLAAVRRVATPSLANGAAEPVDELRARLVSAMAQAVPVDGVAGVAFGAALDHRSGIVYASAPLWGSCTRPFDLAGALARARPDVRWHVVNDVTAALLHLAAGPVGASCRKLLLVTVSTGIAGRTLDRRSGEIPVDGCGLQGEIGHLPATTSIAGRPVTLACDCGQPDHVSSYSSGPGIRRLAAVLRERDPDAWRGSALDGPGPFETLLPAALDAADPVAEELLRAATRPVADVVRSALCLDPELDVVAFTGGVVHALGAHYRRALLAHLNAQGIYLTSALAPESITERLLVCREGEADPLVGAGLAAERTARS	MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAVTSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVISKNDKLLEKYIVGEKLTIQELMYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCSEMNENDSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNGEMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWNDKTVPILRTRIEPIKIEEREKLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIYLEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREGINYGLEQGLYGWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYLSFILFTPQGYFSRAYKDAQKHCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQAVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN	52.66	gnl|BL_ORD_ID|1106|hsp_num:0	1171		
BGC0001038.1|Pyralomicin_8 # 6768 # 8003 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=5bp;gc_cont=0.695	BGC0001038.1|Pyralomicin_8 	6768	8003	+	Loose	900	26.1794	adeH	22.06	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGGTATCGGCGCAGACTGATCAGATTCCCGAGCAGGGGTTGTTCGCATCCGAAGGGCCGGGTGGGCCATGGTGGCGGCTGAACACCAGGCAGCCGGTGAGCTACGAGGTGCGGCTGCACCCGCGGCTCCTCGACCCCGCAGACCCCACCCTGGCCGACGCGGGCGCCGCCGCCGCGCAGCCGGCGGGACAAGAGCGCCGCAGGCTTCTCGTCGTCGAGAGCACCGTGTACGAGCTGTACGGTTACGAGATCTCCCGGTATTTCACCGAGCAGAAGGTGGACTACGAGGTCCTGGTCATCGACGCGCACGAGCGCGTCAAGACGATGGACCTGGTCATGAAGGTGGTCGCGGCCATGGACGGGTTCGGCATCGTCCGGCGCGCGGAGCCGGTCATCGCCTTCGGCGGCGGCGTGCTGACGGACGTGGCGGGGCTGGCCAGCAGCCTCTACCGGCGCTCCACGCCACACGTCCGGGTGCCGACGACGCTGGTAGGCATGATCGACGCGGGGATCGGCGCGAAGACCGGGGTCAACCTCGGCCAGCACAAGAACCGGCTGGGCGCCTACCACCCGGCGGTGACCACGCTGATCGACACGCAGTTCCTGCGCACCCTGGACGAGCGCCACATCGCCAACGGCCTGGCCGAGATCCTCAAGATCGCTCTCATCAAGGACGCCGGGTTGATGGAGTTGCTGGAGAGCGACGGCGCCCGGCTCATCTCCGAGCGCATGCAGGCCGCTGACAGCCTCGACCAGGGGCGGGGCGCCAAGGAGGTGATCCGGCGCGCTATCCAGGGCATGCTGTCGGAGCTCCAGCCGAACCTGTGGGAGCACCGCCTGACCCGGCTCGTGGACTACGGCCACTCCTTCTCCCCTGCCATCGAGATGCGCGCGCTGCCCGAACTGCTGCACGGCGAGGCCGTCTGCGTGGACATGGCGTTCTGCACGGTGCTGGCGCGGCATCGGGGCTGGCTGACCCGGGAACAGCAGGACCGCATCATCCGGCTGATGGGCGAGCTGCGACTGCCCTCCTGGCACCCGGTGTGCACGTCGGCGCTGATCACCCGAGCCCTGCAGGAAACCACGCGGCACCGGGACGGCCGCCAGCGGCTCCCACTTCCCGTGGGCATCGGCCAGGCGTGCTTCGTGGATGACCTGAGCGACACCGAACTGGTCGCCGCTCTGGCCGAGCTGCGGGAGCTGGGGCACCTGCGCGAGGACGTCGCCCTCTGA	MPVSAQTDQIPEQGLFASEGPGGPWWRLNTRQPVSYEVRLHPRLLDPADPTLADAGAAAAQPAGQERRRLLVVESTVYELYGYEISRYFTEQKVDYEVLVIDAHERVKTMDLVMKVVAAMDGFGIVRRAEPVIAFGGGVLTDVAGLASSLYRRSTPHVRVPTTLVGMIDAGIGAKTGVNLGQHKNRLGAYHPAVTTLIDTQFLRTLDERHIANGLAEILKIALIKDAGLMELLESDGARLISERMQAADSLDQGRGAKEVIRRAIQGMLSELQPNLWEHRLTRLVDYGHSFSPAIEMRALPELLHGEAVCVDMAFCTVLARHRGWLTREQQDRIIRLMGELRLPSWHPVCTSALITRALQETTRHRDGRQRLPLPVGIGQACFVDDLSDTELVAALAELRELGHLREDVAL	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	85.09	gnl|BL_ORD_ID|505|hsp_num:0	542		
BGC0001038.1|Pyralomicin_9 # 8184 # 8747 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.720	BGC0001038.1|Pyralomicin_9 	8184	8747	+	Loose	500	26.1794	Laribacter hongkongensis ampC beta-lactamase	34.62	3004292	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	GTGCGCATGCTCCGTTCGCGTCTGATGTACCGCAACGCGTGGATGTCGGTGCGGGAGGACGACGTCGAGCTGCCGGACGGCTCGGTCGGCCTGTACGGCGTGGTCGACAAACAGGACTTCGCCCTGATCATTCCCGCCGAGAACGACGGTTTCCACATCGTGGAGCAGTTCCGCTACCCGGTCGCCGACCGCTGCTGGGAGTTTCCGCAAGGGTCCTGGCCTGCCCATGCCCCGGGCGAGCCCGGCCCGGGACGGTCGCTGCCGGCGGAGGCGGTCCGCCTGGCCGCCATGGAGCTGCGCGAGGAGACCGGCCTGTCCGCTTCGTCCTTCACCCACCTGGGGCGCGTCCACGCCGCGCACGGCTATTCCAGCCAGGGCTGTCACGTGTTCCTGGCCGAGGGGCTCACCCGGGGCCGGCCGCAGCGCGAGGCCACCGAGGCCGACATGCGGCAGCTCTGGGTGAGCGAGAGCGACCTCGACGACATGGTGGCCACGGGACGCTTCGTCGACGCCATGTCGCTGGCCGCGCTGGCCCTGCTCGGCCGGGCCCGCCGGGCCCGCTGA	MRMLRSRLMYRNAWMSVREDDVELPDGSVGLYGVVDKQDFALIIPAENDGFHIVEQFRYPVADRCWEFPQGSWPAHAPGEPGPGRSLPAEAVRLAAMELREETGLSASSFTHLGRVHAAHGYSSQGCHVFLAEGLTRGRPQREATEADMRQLWVSESDLDDMVATGRFVDAMSLAALALLGRARRAR	MKKRITPFSRFASKGLFACSAGMLLVTVAHAANTAAAPAGMDAMVQTVMQAHQIPGMAIAIIQPGKTTYHNYGVASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASRYVAALRGSAFDRITLRQLGTYSAGGLPLQFPDNVTTPADVLAYYQHWQPVHPAGTTRLYSNPSIGLMGLAASQATGESFAGLLGTTVLHPLGMNSTYLQVPPEARSRYAMGYTAAGKAVRVSPGPLDEETYGVKSTTADMAGFLLAHMDPARSKGALQSALQQTRVPVYCAGQTRQGLGWESYQDWKNLDVLLAGNSNQMVFEPQPVKACPAGTMNDPDVWVNKTGSTAGFGAYAVFLPARQTGIVILANRNFPIADRIRLAHGILTALH	47.95	gnl|BL_ORD_ID|2499|hsp_num:0	2845		
BGC0001038.1|Pyralomicin_10 # 8811 # 9446 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.686	BGC0001038.1|Pyralomicin_10 	8811	9446	-	Loose	390	56.225	evgA	23.56	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGATGCTGGCAATGGATTCGCGCTTGATTCGCGGCGCCATCGCGGCCGTGCTGGAGCTCGAAGCCGACATCACCGTGGTGGGCGAGACCGATCGATGGGAATGCGTGCAGCGCACCGCTCAGCGCTGCCGTCCGGACGTCGTCGTCATCGACGCCGACATGAGCGGCGGCTCGGCCCTCACCGCCGTCACCCAGCTGCGCAAGCACACCCCCGCCTGCCGGGCTCTGCTGGTCACGGCGCACAAATCGCCCGAGCTGCTGCGGCGGGCGATGAAGGTGAACGTCTCAGGAATCCTGCTGAAGGACTCCTCGACGGACGAGCTGGCCCGGGGGATCAAGGCGATAGCCGCCGGCGAGCAGGTCGTCGACCAGGAGCTGGTCATCGCGGTGCTGAACGCGGAGCCGAACCCCCTGACCAAACGCGAGACGGACATCCTGCAGATGATCTCGACGGGCGCCGAGCCCGGCGAGGTGGCCAGGCGCCTCGGTCTGAGCATCGGCACCGTGCGCAACTACCTGGCCACCATCGTGACCAAGCTCGACGCGCGCAACCGGGTGGACGCGATCCGCATCGCCGAGGAGTCGGGCTGGCTGCTGCCCGCGGACGAGTCCGAGGCCCTGTTCGACGCCTGCTGA	MMLAMDSRLIRGAIAAVLELEADITVVGETDRWECVQRTAQRCRPDVVVIDADMSGGSALTAVTQLRKHTPACRALLVTAHKSPELLRRAMKVNVSGILLKDSSTDELARGIKAIAAGEQVVDQELVIAVLNAEPNPLTKRETDILQMISTGAEPGEVARRLGLSIGTVRNYLATIVTKLDARNRVDAIRIAEESGWLLPADESEALFDAC	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	103.43	gnl|BL_ORD_ID|958|hsp_num:0	1015		
BGC0001038.1|Pyralomicin_11 # 9587 # 9892 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.552	BGC0001038.1|Pyralomicin_11 	9587	9892	+	Loose	910	23.0978	smeS	37.14	3003067	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCAGTGCAGGGCCGAAGTTTAGTGATCCATTGCGGAGAATATGGAATGTCATACACCGATGTCAACCCTTACATGCGCATATTGAGGTCAGCGGGAAATATTGCGGTCACCGCAAAACACGACGCACCAGGGACCGAAAGTCGGGATTGCTGCGAATACCGCATTTCCTCGTCCGCGCCCGACCTCCACAGCAAGTGCGTCCGGCCCACCGCGTTACTTGCTCCCACAAGACCGCACCAGTACATTGGTCCGCAACCGGATCAACGTTCCAGTGGTAGCTCAATGTTCAAGGAGCTCGTGTGA	MAVQGRSLVIHCGEYGMSYTDVNPYMRILRSAGNIAVTAKHDAPGTESRDCCEYRISSSAPDLHSKCVRPTALLAPTRPHQYIGPQPDQRSSGSSMFKELV	MAFAMAKFQLKFGLTAKTFLAIFTACLLVLAVNGIASRVAFQTGFLDYLNDQGDLRMQRLMPHLQREYREHGGWEHLHGDGDRWARLLRPDLAHGHEGPVPSLSDQTGVPSRLGLFDAQHRFVAGNPDATSDDEPHAVQVDGQTVGWLGMVPFQTVIATNDLNFYNTQVRAWWVIGIALLLVTVLLAWLVSRALRQRLAKLAAATHRLAAGDYATRIERTSDDELDALVNDFNRMAQALDDTERNRRAFIADISHELRTPLAVVRAELEAIEDGIRPLDRANLVGLQGEIRQLGKLIDDLHDLSMTQSGGLAYRFAPLDLVALLRSELNGMRVRFANAGLALEEDLPATPLQVSGDERRLQQVLANLLENALRYTHAGGRVRVQAARVPAGVQLVVEDTAPGVPPDKCALVFERFYRVESSRNRASGGSGLGLAISHNIILAHHGVIHAAPSPLGGLRVVITLPEPA	21.63	gnl|BL_ORD_ID|319|hsp_num:0	342		
BGC0001038.1|Pyralomicin_12 # 9889 # 11370 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.719	BGC0001038.1|Pyralomicin_12 	9889	11370	+	Loose	1000	194.512	efpA	34.31	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAAGAGTGCGAGGAGCACGGGATCGACGGCGGCCGGCGCGACACGGTGGTGGGTCCTGGCCCTCGCCGGGACGGCCCAGCTGATGGTCGTGCTGGACTCCACGGTGGTCAACATCGCCCTCCCGTCCATGCAGGACGACCTGAAGATGTCCGACGCGACGCGCGGCTGGGTGGTGAGCGCCTACACCCTGGCGTTCGGCGGTCTTCTGCTGATCGGCGGCCGGCTGGCCGACCGCTTCGGGCAACGGCTCGCCTTCGTCGCGGGCCTGCTGGGCTTCGCCGCCGCCTCGGCGCTGGCCGGGCTGGCGCCCAACGCGCCACTGCTGTTCGCCGGGCGGGCCGCGCAGGGCGCCTTCGCCGCCCTTCTGGCGCCCACCGCGCTGTCCCTCATCACCACGACGTTCACCGAGGCCCGCGAGCGCACCACGGCGTTCGGGGTGTTCGGGGCGCTCACAGGGGTGGGAGCGGCCATCGGGCTGCTGGTCGGCGGGCTGCTCACCCAGTACCTGTCGTGGAACTGGTGCCTGCTGATCAATATCCCGATCACCGCGCTGGCGCTGGTGCGGGTGCCCGCCGTCATCCCGGCCACCACACCGGTGCGCGGCAGGCCGCTGGACCTGGCCGGGATGGCGCTGAGCATGCTGGGCATGCTGGCGATCGTCTATTCGCTGTCCGAGATGGCCACCCAGGGCTGGTCCAGCCCGCTCGTGCTGGCGTTCCTGGCCGTCGGCCCCCTGCTGCTGGTCGCCTTCATCGCCTGGGAGGCCAGAAGCAGGCATCCCCTCCTGCCGCTGCGCGTGCTGCGCGACAGGACGCGGGCCGGCGCCTTCCTGGCGATCGGGCTGCCGCAGGTCTCGATGTTCGGCTTCTTCCTCTTCCTGACCTACTACCTGCAGCAGATCCTGGGCTACAGCCCGCTGCAGACCGGCCTGGCCTTCCTGCCGCTGTCGCTGGCCATCGGCGTCGGCTCGACGGTGATCACCAAGATGCTCGAACCGAAGCTGAGCCCCCCGGCGCTCATCATCCCGGCCCTGCTCATGATGGCGGCCGGCATCGCGCTGCTCATCGGCGCGGGGCCCGGCGGGTTCTCCGTCTACCTGACGCTGCTGCTGCCCGCCGAGTTGCTCATCGGCCTCGGGCTCGGCTGCGTGATCGCGCCGTCGATCAGCATGGCCACGGCGGGCGTCGGCGCCGACGACGCCGGGGTGGCCTCGGCCACCGTCAACGTGGTGCAGCAGCTCGGCGGCGCGATCGGCATCGCGTTGCTCAACACCGTCGCCACCACCGCGGCCGCCGGTTACCTGGCGACGTCCGGCACGAGCGACGCCCGGGCCCGCGCAGACGCGATCATGCACGGGTTCAGCGTCTCGCTCGCCATCGCGGCCGCGATCGTCGTGGCGACCGCCGTGATCGCCGGCTTCATGCTGCGGTCCCGGGCCACCCTGCCGCTGCCGGAGAGTCGCGAGGAGGAGGTCGCTTAG	MKSARSTGSTAAGATRWWVLALAGTAQLMVVLDSTVVNIALPSMQDDLKMSDATRGWVVSAYTLAFGGLLLIGGRLADRFGQRLAFVAGLLGFAAASALAGLAPNAPLLFAGRAAQGAFAALLAPTALSLITTTFTEARERTTAFGVFGALTGVGAAIGLLVGGLLTQYLSWNWCLLINIPITALALVRVPAVIPATTPVRGRPLDLAGMALSMLGMLAIVYSLSEMATQGWSSPLVLAFLAVGPLLLVAFIAWEARSRHPLLPLRVLRDRTRAGAFLAIGLPQVSMFGFFLFLTYYLQQILGYSPLQTGLAFLPLSLAIGVGSTVITKMLEPKLSPPALIIPALLMMAAGIALLIGAGPGGFSVYLTLLLPAELLIGLGLGCVIAPSISMATAGVGADDAGVASATVNVVQQLGGAIGIALLNTVATTAAAGYLATSGTSDARARADAIMHGFSVSLAIAAAIVVATAVIAGFMLRSRATLPLPESREEEVA	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	93.02	gnl|BL_ORD_ID|2245|hsp_num:0	2427		
BGC0001038.1|Pyralomicin_13 # 11370 # 12515 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.746	BGC0001038.1|Pyralomicin_13 	11370	12515	+	Loose	1000	73.559	vmlR	31.05	3004476	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGGCCCGTCTGGACGTGGCCGGTCTCACGTACGTACTGCCCGACGGGCGCACGCTTCTGGACAGCGTCTCCTTCGAGCTCGGCCCGGGGATCACGGCCGGGCTGGTCGGTCCCGCCGGGTCCGGCAAGTCCCTGCTGCTGCGGCTGATCGCCCGAGAGCTGCGACCCGCCGCCGGCCGGATCTCCACCGAGGGGGCGATCGGCTACCTGCCACAGGAGCGCGGCGCGACGTCCTCGCGCAGACAGGCGGCGCTGGAGACGCTGTTACGCGGGTCGCACGAACTGCTCCTGCTCGACGAGCCCGACGACCACCTCGACGTGAGCGGCAAGGAACGGCTGGAGGACCAGCTGCGCGGCAGCGCCAAGACGGTGTTGCTGGTCTCGCGCGACCGCCAGCTGCTGGCCAACGCGGCCAACCGGATCATCTTCCTGGACCAGGGCCGCCTCGGCACGCACGGCGGCGGCTACGCCACCTACAGCGGCTCCCGGTGCCCCCGGCCGGCGGACGCGGGTGGCGCCGAGCTCAGTGGCGAGCACGCCTTCACCTGCCGCCGGCTGCGGTTCGCCGGCCTGACGGCCCCTTTCGACCTGCGGGTCCGCTTCGGCGAGCGGGTCGCACTGCTCGGCTCCGACGCGGGCCGGGCTCTCTTCCTGTCGCTCCTGGCCGACCCGCCCGGCCTGGGGCAGGCCGCGGCGCCGTACCGGGGGATCCTCGACGTCCACCCTCGGGCGCGGGCGATGCGCCTCGATCACCGGTGGCCCGGGCCCGGGCTGAAGGGCCGGAGCGTGGCTGGCATCGTGATGGACCAGCGCCGGTGCGGGCGCGAGGAGGCCATGGCCCTGCTGACCCGCTACGGCATCTCCAGGGAGTGGATGCGGCCCTACGAGACGCTGCGCACCGCCCAGCGCCGGGCGCTGCGCATCCTGCTGGCCGAGGTCGAGGGGGTGAACCTGCTCCTGCTGTCCGACCCCACCGGGGATCTGGACGTTCCCGGCGCGGAGACCGTGCAGCACGCCGTCCGCGGCTTTCCCGGCGCCGTCGTCGCCAGCACGTGCGACCGCTGGCTGACCGCGGAGTTCCCGCGCCTGCTGCACTTCTGCGCCGACGGCCGGGTGCGCGAACCCGGGGCCGGCGCCCGGTGCTGA	MARLDVAGLTYVLPDGRTLLDSVSFELGPGITAGLVGPAGSGKSLLLRLIARELRPAAGRISTEGAIGYLPQERGATSSRRQAALETLLRGSHELLLLDEPDDHLDVSGKERLEDQLRGSAKTVLLVSRDRQLLANAANRIIFLDQGRLGTHGGGYATYSGSRCPRPADAGGAELSGEHAFTCRRLRFAGLTAPFDLRVRFGERVALLGSDAGRALFLSLLADPPGLGQAAAPYRGILDVHPRARAMRLDHRWPGPGLKGRSVAGIVMDQRRCGREEAMALLTRYGISREWMRPYETLRTAQRRALRILLAEVEGVNLLLLSDPTGDLDVPGAETVQHAVRGFPGAVVASTCDRWLTAEFPRLLHFCADGRVREPGAGARC	MKEIVTLTNVSYEVKDQTVFKHVNASVQQGDIIGIIGKNGAGKSTLLHLIHNDLAPAQGQILRKDIKLALVEQETAAYSFADQTPAEKKLLEKWHVPLRDFHQLSGGEKLKARLAKGLSEDADLLLLDEPTNHLDEKSLQFLIQQLKHYNGTVILVSHDRYFLDEAATKIWSLEDQTLIEFKGNYSGYMKFREKKRLTQQREYEKQQKMVERIEAQMNGLASWSEKAHAQSTKKEGFKEYHRVKAKRTDAQIKSKQKRLEKELEKAKAEPVTPEYTVRFSIDTTHKTGKRFLEVQNVTKAFGERTLFKNANFTIQHGEKVAIIGPNGSGKTTLLNIILGQETAEGSVWVSPSANIGYLTQEVFDLPLEQTPEELFENETFKARGHVQNLMRHLGFTAAQWTEPIKHMSMGERVKIKLMAYILEEKDVLILDEPTNHLDLPSREQLEETLSQYSGTLLAVSHDRYFLEKTTNSKLVISNNGIEKQLNDVPSERNEREELRLKLETERQEVLGKLSFMTPNDKGYKELDQAFNELTKRIKELDHQDKKD	69.65	gnl|BL_ORD_ID|2645|hsp_num:0	2907		
BGC0001038.1|Pyralomicin_14 # 12608 # 13444 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.722	BGC0001038.1|Pyralomicin_14 	12608	13444	+	Loose	600	33.4982	emtA	25.35	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGAACCGGCAACGCCACGACGAGATCGCGCGCTTCTACGACGACGTCACCGACCCCTACGTCGAAGCGTGGGACGGCAACCTGCACATGGGCTACTGGGAGACGGCGGCGGCGCGGCCGTCCATCGCCGAGGCGACCGACCGCCTCACCGGCGAGGTGCTCGACCGGCTGCGGACGAGCCCCGGCGACCACGTACTCGACGTCGGCTGCGGCATCGGCAAGCCCGCGCTCCGGCTGGCCCAGGAGCGCAAGGTCGACGTCGTGGGCGTGTCGATCAGCGAGCAGCAGATCGAGATCGCCGCCGCGTCGGCGCGGGCCGTCCCGGTGCCCACCCAGGTCTCCTTCCGCACGGCCGACGCCATGGACCTGCCCTTCCCCGACTCCAGCTTCGACGCCGTCCTGTCCTTGGAGGTGCTCCACCACGTGGCCGACCGCGCCAGGGCGCTGCGCGAGATCGCCAGAGTGGTGCGGCCGGGCGGCTCGGTCGTCATCGCCGACTTCGCGCTGCGTGCCCCGGTGCCCGAGGAGCACCGCGAACTGGTGGACCGGTTCGCCGCCGCCTGCAACCTGGTGACGCTGACCGAGATCGACGAGTACGTCGCGGAGTTCACCGGGGCGGGGCTGGAACTGGTCGAGGTGACGGACGTGAGCGAGCACGTACGGCCTTCCATGCGCCAGCACGCCGAGGCCATGGTGGCGGCCCGCGACCGCCTCGGCCCCGTCGTCGGGGCCGGCAACCTCGACCTGATGGTGGAGCTCACCGAGCGCTATGCCGAGCTGCCCCAGTTCGGCTACGTCATCCTGCGCGGCGAGGGCCGGCGGACAGCGGCGGCCTGA	MNRQRHDEIARFYDDVTDPYVEAWDGNLHMGYWETAAARPSIAEATDRLTGEVLDRLRTSPGDHVLDVGCGIGKPALRLAQERKVDVVGVSISEQQIEIAAASARAVPVPTQVSFRTADAMDLPFPDSSFDAVLSLEVLHHVADRARALREIARVVRPGGSVVIADFALRAPVPEEHRELVDRFAAACNLVTLTEIDEYVAEFTGAGLELVEVTDVSEHVRPSMRQHAEAMVAARDRLGPVVGAGNLDLMVELTERYAELPQFGYVILRGEGRRTAAA	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	81.52	gnl|BL_ORD_ID|2272|hsp_num:0	3368		
BGC0001038.1|Pyralomicin_15 # 13496 # 14596 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=10bp;gc_cont=0.726	BGC0001038.1|Pyralomicin_15 	13496	14596	-	Loose	1200	25.409	otr(A)	34.09	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAGGAAGACGACGACCAAGCTGCCCGACGGCCGCGAGCTGATCTACTACGACACCCGCGACGACGTGGTCAGGGATCCGGTGGACCCGCGTCCGGCCACCGCCCCGGCCAGGACGACCGAGATCCGCTACGACGCGCTGCGCGAGGAGTGGGTCCTGATCGCCGCCCACCGGCAGGGACGCACCCACCACCCGCCGACCGAGGAATGCCCGCTGTGCCCGTCCCCGGAGGGCAACAGCGAGATCATGGCCGACGACTACCAGGTGGCCGTCTTCGAGAACCGCTTCCCGGCCCTGGCCGGCGACGGCGACGCGGAAAGCGCCCGCGAGCGCCTGCACGCGCTGCGCCGGCCCGGCCAGGCGTGGCGGGCGGCGCCCGGGGCGGGCCGCTGCGAGGTGGTGTGTTTCAGCGCCGACCACGACCGCTCCTTCGCGGACCTGCCCGCAGAACAGGTCTCGCTCGTCCTCGACGTGTGGACCGACCGCACCGCCGAGCTGTCGCACCTGCCCGGCGTCGAGCAGGTGTTCCTGTTCGAGGACCGCGGCAAAGAGACCGGCATGAGCCTGGTCCACCCGCACGGGCAGATCTACGCCTACCCGTTCGTCACCCCGCGGACCCGGCGGGTGCTGGCGGCGGTGGCCGGGCACCGGTCCGCGACCGGCCGGAACCTCTTCGACGACCTGGTGGCCGCGGAGTCGTCCGACGGCAGGCGCCTGGTCGTCGAGGCCGAGCACTGGACGGCGTTCGTGCCGTACGCCGCGCACTGGCCCTACGAGGTGCACCTGTACCCGCGCCGCCGGGTGCCTGATCTGACCGGGCTGGACGACGCCGCCCGGGCCGAGTTCCCCGGCGTCTACCTCGACCTGCTGCGCCGCTTCGACCGGCTGTTCGGCGCCGCCGGTCCGGCGCCCTACATCTCCTCCTGGATCCAGGCACCGATCTCCGACCGGGAGGAGTTCGCCCTGCACCTGGAGCTGTTCACGGTGCGCAGGACACCCGCCAAGCTCAAGCACCTGGCCGGCTCCGAGCTGCTCATGGACGTCTTCGTCAACGAGATCCCGCCGGAGTCGGCCGCGGCCAGGCTGCGCGAGCTGGGGTGA	MRKTTTKLPDGRELIYYDTRDDVVRDPVDPRPATAPARTTEIRYDALREEWVLIAAHRQGRTHHPPTEECPLCPSPEGNSEIMADDYQVAVFENRFPALAGDGDAESARERLHALRRPGQAWRAAPGAGRCEVVCFSADHDRSFADLPAEQVSLVLDVWTDRTAELSHLPGVEQVFLFEDRGKETGMSLVHPHGQIYAYPFVTPRTRRVLAAVAGHRSATGRNLFDDLVAAESSDGRRLVVEAEHWTAFVPYAAHWPYEVHLYPRRRVPDLTGLDDAARAEFPGVYLDLLRRFDRLFGAAGPAPYISSWIQAPISDREEFALHLELFTVRRTPAKLKHLAGSELLMDVFVNEIPPESAAARLRELG	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	55.20	gnl|BL_ORD_ID|1221|hsp_num:0	1273		
BGC0001038.1|Pyralomicin_16 # 14593 # 15915 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=9bp;gc_cont=0.733	BGC0001038.1|Pyralomicin_16 	14593	15915	-	Loose	700	85.1149	oleI	26.35	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGGGACGGATCCTCGTCGCCACCACGCCGGGCGAAGGTCACGTGAACGGGATGGTGGAGGTGGCGCGCGCGCTCGTCCGCGCCGGCCACGAGGTGCGCTGGTACACGGGACGGGCCTTCCGTCCCAAGGTCGAGGCCGCCGGGGCCGTGTTCGTGCCCATGTCGCGCGGGCACGACTGGGGCGGCAGGACCAGGGAGGAGGCGTTCCCGCACCACGCGGGGCTGACCGGCGTGCGGAGCATGGTCGCGGCCTTCCGCGACATCTTCTTCCGCGCCGCCTACGGTCAGATGGTCGACATCCTGGAGATCCTGGACGAGTTCCCGGCCGACGTGATCGTCTCCGGTGAGACGATCTTCGGCGCCAACTTCGCCGCCGAGCGGCGCGGCATCCCGATCGCCTGGGTGGCCACCTCCATCTACATCTTCGGCAGCCGCGACACCGCTCCGCTCGGACTGGGCCTGCCCCCTGCCGCCTCGCCGGCCGGCCGGCTGCGCAACAGGGCGCTCAAGGTGCTCTCCCGCACGCTGCTGAAACCCCTGCGGGAGGTGCGCAGAGACGCCGACGTGACCCGCTCGCGGGCCGGGCTGAGACCGATCGGCGCCGGCCCGTTCGAGAACATCGTCCACCCACCCGACCTGTACCTGATGGGGACGGTGCCCTCCTTCGAGTACCCCCGCACCGACATGCTGCCGCAGACCCACTTCGTCGGGCCCTTCGTCGGCCCGCCGCCCCAGGGGTTCCAGCCGCCCGCCTGGTGGGACGAGCTGGACGGGCGCCGCCCGGTCGTCCACCTCACCCAGGGCACGGTGGCCAACGACGCCGGCCGGCTGCTGACGCCGGGCCTCAAGGCGCTGGCCGGCCTGGACGTGACGGTGGTGGCGACCACGGGTGTCCCCCCGGACACGCTCGACCTCGGCCCCCTGCCGGACAACGTGCGGCTGGAGCGGTTCGTCCCGCATTTCGAACTGCTGCCCCGAGTGGACGTCATGATCACCAACGGCGGCTATGGCGGGGTCAACACGGCGCTGTCGCACGGGGTCCCGCTCGTGGTCGCGCCGGCCACCGAGGAGAAGCACGAGGTCGCGGCCCGCGTCGACTGGGCAGGCGTGGGCATCGGGCTCAGCCGCCGCAACCTGTCGGCCGACGCGCTGCGCCGCGCGGTCAGCACGGTGCTGGCCACGGACTCCTACCGCCGCCGCGCCCGCCAGTTGCAGGAGGAGTACCGCAGACACGACGGGCCGCGGCGCGCGGTCGCGCTGATCGAGAGCCTGGCCGGGCTGCCGCAGTCCCGGCCCGCCGCCGAAGGGAGCCTGCGCGGATGA	MGRILVATTPGEGHVNGMVEVARALVRAGHEVRWYTGRAFRPKVEAAGAVFVPMSRGHDWGGRTREEAFPHHAGLTGVRSMVAAFRDIFFRAAYGQMVDILEILDEFPADVIVSGETIFGANFAAERRGIPIAWVATSIYIFGSRDTAPLGLGLPPAASPAGRLRNRALKVLSRTLLKPLREVRRDADVTRSRAGLRPIGAGPFENIVHPPDLYLMGTVPSFEYPRTDMLPQTHFVGPFVGPPPQGFQPPAWWDELDGRRPVVHLTQGTVANDAGRLLTPGLKALAGLDVTVVATTGVPPDTLDLGPLPDNVRLERFVPHFELLPRVDVMITNGGYGGVNTALSHGVPLVVAPATEEKHEVAARVDWAGVGIGLSRRNLSADALRRAVSTVLATDSYRRRARQLQEEYRRHDGPRRAVALIESLAGLPQSRPAAEGSLRG	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	103.77	gnl|BL_ORD_ID|1723|hsp_num:0	1824		
BGC0001038.1|Pyralomicin_17 # 16096 # 17400 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.707	BGC0001038.1|Pyralomicin_17 	16096	17400	+	Loose	1080	41.9726	rosB	27.44	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCCGAAGGAAAACGCCGAATGGCAGATCATGACGACTGTCGCGGGCATCGGAGTGATCCTGCTGGTCGCGACCATGGTCGTCGTCGTCGCGCGATCAGTGCGGCAGCCGGCGGTGATCGGCGAGATCCTGGCGGGCGTCATCCTGGGGCCCAGCGTGCTGGGGCTGTTCCCCGGGGACCTGACCGGGCTCCTCTTCCCCGCCGAGCTGCGGCCGCAGTTGTCGGTCGTGGCGCAGATCGGGGTCCTGCTCTTCCTGTTCGTCGTCGGCTGGGAGTTCACCCCCGCCACCATCCGCGGCCACCGGCGCAGCACGGGCCTGATCTGGCTGTCGTCGATCGTGACCCCGATGCTGCTCGGCGTGGCGATGGCCTGGCTGCTGTACCCGCGCTACGGCGTCGTGGACGGCCGCCAGGTGGGGGCTGCTCGGCTTCCGCTCTACCTCAGCGTGGCCATGTCCGTGACGGCCTTCCCGGTGCTGGCCAGGATCATCTCCGAGTACCGGCTGCAGAGCAGCCGGGTAGGCGTGCTCGCCCTCGCGCTGGCCGCCGCCGACGACGTGTTCGCCTGGTGCGTGCTGGCCGCGGTCGTCGCCTTGGTCACCACCAGCGGCTCGGCGGCGCTCATCTCGGTACTGGCCTGGTCGGTGATCTACGTCGTGGCCATGTTCTGGGTGGTGCGGCCGCTGTTGACCTGGGCGTTCCAGCGGATGAGCGCGGCCCAGCCGTGGCCGGTCATGGTCACCGCCGCGGGGGTCCTGCTGTCGGCCTACGTGACCTCGGTGATCGGCATCCACGCCATCTTCGGGGCCTTCATGTTCGGTCTGGTGATGCCGCGCTCCCTGGCGCCCGCGCTGCGCGCAGCGGTGCAGGTCCCGCTCGAACGCGTCGGCCAGCTGCTGATGCCGGTCTTCTTCGTGGTCACCGGGCTCTCGGTCGACCTGACGACGATCACCGGGATGACGCTGCTGATCACCGTCGGCATCGTGGTGGCGGCCTGCCTGGGCAAGCTGGGCGGGGTCACCGCGGCCGCCCGGCTCAGCGGGCTCAGCCCCAGCGGCTCACTGGTGCTGGGCCTGCTGATGAACACCCGGGGCCTGACCGAGCTCGTGGTGCTCAACGTCGGTCTCGGGCTGGGCCTGCTCAGCACCGAGCTGTTCAGCGCCATGGTCGTCATGGCCGTGGTCACCACGGCGATGGCCGCCCCGTTGCTCTCCCTGACCCTGCGGTCCTCGGCCGCCGTGTCGTCCCGGCCGGATCTGCGTCAGGACGCCGGTCCGGCGGCGCCGGCCCTGCCCACCCACTGA	MPKENAEWQIMTTVAGIGVILLVATMVVVVARSVRQPAVIGEILAGVILGPSVLGLFPGDLTGLLFPAELRPQLSVVAQIGVLLFLFVVGWEFTPATIRGHRRSTGLIWLSSIVTPMLLGVAMAWLLYPRYGVVDGRQVGAARLPLYLSVAMSVTAFPVLARIISEYRLQSSRVGVLALALAAADDVFAWCVLAAVVALVTTSGSAALISVLAWSVIYVVAMFWVVRPLLTWAFQRMSAAQPWPVMVTAAGVLLSAYVTSVIGIHAIFGAFMFGLVMPRSLAPALRAAVQVPLERVGQLLMPVFFVVTGLSVDLTTITGMTLLITVGIVVAACLGKLGGVTAAARLSGLSPSGSLVLGLLMNTRGLTELVVLNVGLGLGLLSTELFSAMVVMAVVTTAMAAPLLSLTLRSSAAVSSRPDLRQDAGPAAPALPTH	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	77.09	gnl|BL_ORD_ID|476|hsp_num:0	507		
BGC0001038.1|Pyralomicin_18 # 17413 # 18555 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.734	BGC0001038.1|Pyralomicin_18 	17413	18555	+	Loose	600	25.0238	oleC	34.78	3003748	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGTGGACTTCGGTTGGAACGCCGAGCAATCGGCCCGCTACGAGCACCTGCTGACCCGGCTGCGCCAGGTGTGCAAGGACTCGCACACCGAGCACCCCCTGGGGGGCCGGCGACGGCACTGGCGCTGCCTCGGGGAGCTGGGCGTGCTCGGCTCCTGCGTGCCCGCCGAGCACGGCGGGCAGGGGCTCGGTGCGCTCGACACGGCCCGGGTGTTCGAGGCGGCCGGGCGGGGCTGCCGCCACACCGGGCTGGTGTTCGGCGCGAGTGCGCACCTGTTCGCCTGCACGATGCCGATCGCCGAGTTCGGCGGGCCCGGCCTGCGCGCCGGGTTCCTGCCGCGCCTGTGCTCGGGCGAGGCGATCGCCGGCAACGCCATGACCGAGACCGAGGCCGGGTCGGACGTCTCGCGGCTGGCCACGAGCGCCCGCCGGGCGCCGGGCGGCTGGGTGCTCAACGGGAAGAAGTCGTTCGTCAGCAACGGGCCCGTCGCCGACGTGCTGCTCGCCTACGCCACCACCGACCCGCGGGCCGGCTACCTCGGGCAGACCGCCTTCGTTGTGGACGCCGGCTCCCCGGGCGTCCGGCTCGGCCCGACGATGGCGAAGATGGGCCTGGACGACTGCGTGGCCTGCGCGGTCCACTTCGAGGACTGCTTCGTCCCCGACGAGCGGGTGCTGGGCGAGCCGGGGCAGGGCGGCCCGATCTTCCAGCGCTCCATGGAATGGGAGCGGGCCTGCCTGTTCGCTGGTTACCTGGGGCTCGCCGACCGCCTGCTGGACCGGGTCAAGGAGCACGCCCGCGCCCGGCGGCAGTACGGCGCGCCCATCTCGCGGCTGCAGGCCGTCTCCCACCGCATAGCGGACATGGCCACCCAGGTCGAGAGCGCCCGCCTGCTGCTGTACCGCGCGTGCTGGCAACTGGATCGGGGCGAGCCGGCGGACCTGGCGATCGCCATGTCCAAGTTGGCCGTCTCCGAAGGGGTGCTGCACAGCGCCCTGGACGCCGTGAGGCTCTTCGGGGCCCGCGGCTACCTGTCCGAGGACGGCATCGAGGCGGCGCTCCGCGACACCGTGCCCGCAGTGATCTTCTCCGGCACCTCCGACATCCAGCGACAGCTCATCGCGAGGGAGCTCCACCTGTGA	MVDFGWNAEQSARYEHLLTRLRQVCKDSHTEHPLGGRRRHWRCLGELGVLGSCVPAEHGGQGLGALDTARVFEAAGRGCRHTGLVFGASAHLFACTMPIAEFGGPGLRAGFLPRLCSGEAIAGNAMTETEAGSDVSRLATSARRAPGGWVLNGKKSFVSNGPVADVLLAYATTDPRAGYLGQTAFVVDAGSPGVRLGPTMAKMGLDDCVACAVHFEDCFVPDERVLGEPGQGGPIFQRSMEWERACLFAGYLGLADRLLDRVKEHARARRQYGAPISRLQAVSHRIADMATQVESARLLLYRACWQLDRGEPADLAIAMSKLAVSEGVLHSALDAVRLFGARGYLSEDGIEAALRDTVPAVIFSGTSDIQRQLIARELHL	MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVAGYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFSLTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGDGVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPLAGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDEVFLSLTGHRASAPQDAEPARQEVAV	116.92	gnl|BL_ORD_ID|2102|hsp_num:0	2264		
BGC0001038.1|Pyralomicin_19 # 18552 # 20027 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGGGA;rbs_spacer=9bp;gc_cont=0.728	BGC0001038.1|Pyralomicin_19 	18552	20027	+	Loose	750	26.9498	MexE	26.8	3000803	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAACTCCATCGGCTGCTCATCGAAAGCGCGCGGCGCACGCCTGAGGCCGTCGCCGTGCACGACCACGACGGCCCGGTGACCTACCGCGCCCTGGACGAACTGTCCGATCTCTACCTGTCCGCCCTGCGCCGGCGCGGCGTCGGCCGGGGCGATCGCGTCGTCATCTGGACCGGCAAGCACGTCCAGGCGATCGCGGTGATGCAGGCGGTGCTGCGCCTGGGCGCCGTCTACGTCCCGGTCGCCGGCGCCAACCCGGCGGCCCGGGTCGCCAGGATCGTCCGCGACGCCGCGCCCGCGCTGGTCGTCACCGACGAGGACGCTCCCGGACGGCTCCCCGCCGGGCACGGCCTGCCGCTCGTCGCCTGGCCGGAGCTGGCCGCCGGCGGCGACGCCGACGCCGGCGGCGGCCGGGGCGAGCTCTCCGCAGGGGGCGACGATCCCGCCTACATCCTTTACACCTCAGGCTCGACCGGCACGCCCAAGGGGGTGTGCCTGAGTCACCGCAACGCGCTCGCGTTCGTCGAGTGGGCGGTGCGGGAAATCCGGGTGGGGGCCGGTGACCGGCTCTCCAACCATGCGCCGTTCAACTTCGATCTGTCGGTTTTCGATCTGTATGCCGCTTTCGCGACGGGGGCCTCGGTCCACCTCGTACCTCCGGCGAGCGCCTACGCCCCGCACCAGCTCACGGACTTCCTCCACGAGCGCGCCATCACCGTCTGGTACTCCGTCCCCTCCGTCCTGACCCTGATGTGCCGCGAGGGGGGCCTGCTGGACCGGGAGCCGCCGCCGGGGTTGCGCGCCTGCGTCTTCGCCGGAGAGCCGTTCCCCCTGCAGCACGTGCGGGCGCTGCGCAAACACTGGCCCGGCGTCCGGCTGCTCAACTGGTACGGGCCGACGGAGACCAACGTCTGCACCTCCTACGAGGTGAGCGACGCGGACCTGGACCGCGACCGGCCGCTCCCCATCGGGCGCGCCTGCGCCGGGGACACGGTCACGCTGTCGTCCCCGGACGACGACGGAGTCGGGGAGATCGTCGTCGAGGGGCCGACCGTGATGCTGGGCTACTGGGGCGGCGAGAGGTTGACGGGCCCCTATCGGACGGGCGACTTCGGCCGTCTGGACGCCGACGGCGAGCTGCATTACGTCGGGCGGCGCGACCACCTGGTCAAGGTCCGCGGCAACCGGGTCGAGCTGGGCGAGATCGAGACGGCCCTGGGAGGGCTCGGCTCCGTCGCCGAGGTCGCCGTGCTGGCCGCCGGGGAGGGGGATCACGCGCGCTTGTACGCGTTCGTCGTCCCTGCGCCCGGCCGGCGCCCCTCCCTGTTGGAGGTCAAGCGTCACTGCGCGGGGCTGCTGCCCCCATACATGAACGTCGACCGCCTGCGGCTGCTGGAGACGCTGCCCAGGACCCCGAACGGGAAGACCGACCGAGCTCTGCTGCTGGCCATGACGGAGGAGGGCGGCCCTCGATGA	MKLHRLLIESARRTPEAVAVHDHDGPVTYRALDELSDLYLSALRRRGVGRGDRVVIWTGKHVQAIAVMQAVLRLGAVYVPVAGANPAARVARIVRDAAPALVVTDEDAPGRLPAGHGLPLVAWPELAAGGDADAGGGRGELSAGGDDPAYILYTSGSTGTPKGVCLSHRNALAFVEWAVREIRVGAGDRLSNHAPFNFDLSVFDLYAAFATGASVHLVPPASAYAPHQLTDFLHERAITVWYSVPSVLTLMCREGGLLDREPPPGLRACVFAGEPFPLQHVRALRKHWPGVRLLNWYGPTETNVCTSYEVSDADLDRDRPLPIGRACAGDTVTLSSPDDDGVGEIVVEGPTVMLGYWGGERLTGPYRTGDFGRLDADGELHYVGRRDHLVKVRGNRVELGEIETALGGLGSVAEVAVLAAGEGDHARLYAFVVPAPGRRPSLLEVKRHCAGLLPPYMNVDRLRLLETLPRTPNGKTDRALLLAMTEEGGPR	MEQSSHFSWRYPLALAAVLVLSACGKAPETTQGMAAPKVSVAEVIEQPLNEWDEFTGRLEAPESVELRPRVSGYIDRVAFHEGALVKKGDLLFQIDPRPFEAEVKRLEAQLQQARAAQARSVNEAQRGERLRASNAISAELADARTTAAQEAKAAVAATQAQLDAARLNLSFTRITAPIDGRVSRAEVTAGNLVNSGETLLTTLVSTDKVYAYFDADERVFLKYVELARQAGRDTRSESPVYLGLSSEDGNPHLGRLDFLDNQVNPRTGTIRGRAVFDNAKGEFTPGLYVRLKLVGSKTYAATLIKDEAVGTDLGKKFVLVLDGDNKTVYRTVEMGPKLEGLRIVRSGLSKGDRIVVNGLQRVRPGMQVDPQKVEMASADTLATLARLRQSVGDSEPPKVAASKDNATRNEPRG	118.60	gnl|BL_ORD_ID|1066|hsp_num:0	1067		
BGC0001038.1|Pyralomicin_20 # 20024 # 20614 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.721	BGC0001038.1|Pyralomicin_20 	20024	20614	+	Loose	800	25.0238	ParS	64.29	3005067	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; acridine dye; phenicol antibiotic; penem	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	ATGAGCGGATGGGAGATGTTGCCGATGGCCCTGGCCGGACCCGAGCCGTGCGCGACGCACGTGTTCCCGATGAACGGCGCCACCCAGGAGCGCGCCGAGGAGCGATTGCCGTCGGTGGACGCCGACACCTTCCGCACGGTCATGGGCTCCTTCGCCAGCGGCGTCTGCGTGGTCACCACCACCGGCGGCGACGGATCACCGCGCGGGTTCACCTGCTCGGCGGTGTGCAGCGTGTCCGCCGACCCGCCGCTGCTGCTGTCGTGCGTGAGCAACAAGAGCGGCACGCTCACCGCCGTGCTGGCCAGGGGCAGGTTCGCGGTGAACATGCTGGACCATCGGGCCAGGCGGGTCTCCCAGGTCTTCGCCTCCCCGGTCCCGGACAAGTTCGACCGGGTGCGCTGGGACCGCGGCCCGGTCAGCGGGATGCCGGTGCTGGCCGACGTCGTCGCCTACGCCGAGTGCGAGCTGGAGCGGGCGGTGACCACGGGCGACCACACGCTGCTGGTGGGCCGGCTGGTCGGTGGAAACCTGCGGTCCCACCGCCACCCCCTGGCCTACTGGCGCGGCGGCTACGCCGAAGTCCTGCGCTGA	MSGWEMLPMALAGPEPCATHVFPMNGATQERAEERLPSVDADTFRTVMGSFASGVCVVTTTGGDGSPRGFTCSAVCSVSADPPLLLSCVSNKSGTLTAVLARGRFAVNMLDHRARRVSQVFASPVPDKFDRVRWDRGPVSGMPVLADVVAYAECELERAVTTGDHTLLVGRLVGGNLRSHRHPLAYWRGGYAEVLR	MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR	45.79	gnl|BL_ORD_ID|2851|hsp_num:0	3805		
BGC0001038.1|Pyralomicin_21 # 20696 # 22330 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.728	BGC0001038.1|Pyralomicin_21 	20696	22330	-	Loose	2030	27.335	ceoB	38.64	3003010	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGTGGAAACTCCCAGCACCCCATTCGACGTCGCCGTCCTCGGCACCCACCTGGGCTGCGCCATGCTCGCGGCGATCCTGGCCAAGCAGGGAGTGCGCGTCCTCCTCGTGGACGCCGCCCCCGGCCAGGAGGAGTTCGCCGGGGAGACGACGGTGCCGTACACGGCGGAGGTCTTCTTCACTCTCGCCCGCCGCTTCGACATCCCCGAGCTCGCCGCCTTCGGGCTGACCAGCGCGCTGCCGTCGGAGATCCGGCGCTCCAGCGGGATCAAACGCAGCCTGGGCTTCCTGCACCACAGCGAGGGCCGCCAGCAGGTCCCCGAACAGGCCGTGCAGTTCAACGTCCCGGGCGAGCACGCCGAGTGGCACCTGTATCGCCCGCACGTCGACCAGCACGCCTGGACGATCGCCCGGCGCTACGGCGCGGTGGTCGTGCCGCACCGTCCCGCGGTCGCGGACGTGCGCGTCGGCGCCGGCGGCGCCGACGTGCTGCTGGCCGACGGCTCCCTGCACCGCGCCCGCTTCGTCGTGGACGGCAGCGGCGCGGGCTCCCCGCTGGTACGACGGCTGGGGGCCGAGGACGCGGCGCCGAAACTGCGCTCCCGGTCGCGGGTGCTGGCCACGCACATGTACGGGGTGCGGCCGTACGAGCAGTGCGTGCGGCAGGCGGACTACGTCAGCGCCACCGACTGGTCCATGGGCACGATCAGCCACCTGTTCCCCGGCGGGTGGCTCCAGCTGGCCCACTTCGGCAACGGCGAGGACCCGGTCAACCCGTTGACCAGCGTGGTGCTCAGTCTGGACCCGGGGCGGTACGCGGACCTGCCGGGCGACCCCGAGCAGGCATTCCGCGAGCTGGTGCGCCGCTTCCCCACCCTGGCCCGCTCGTTCAAGGACGCCGTCGCCGCCCGGCCGTGGACCGCCGCCCGGGTCTGGCAGCGCACGGCGGGACCGGCGTTCGGCGAGGGGTGGTTCCTGTTCGATCGCACCTTCAGCCGCAACGACCTGTTCCTGTCACGCGACGTCACCATGACGGCCGAGATGGTCCACGCGCTGGCGCCGGCGCTGGTCGAGGCGGCGCGGCGCGACGACTGGTCGACACCGGCGCTGCGGCGCGCGGCGCTGTTTCAGGAGCGGCTGGTCGACTTCAACGACCGGCTGCTCGCCGGCGCCCGCACCGCCACCACCGACTTCCGGTTGTGGAACGCCTACTCGCGGGTGTGGCTGCTGTGGTCGATGCTCTCGGCCCTGTCGCTCAAGAGCGCCCGCAACCGGTGCCTGGCGCGGGGGCGCTGGGAGGAGGTGGAGCGCTTCGGGGACGACGCGTTCTGGTTCCGCCCGCCTGACGGGCTGCCCGGGCTGCTGGACCGGGCGCTCGGAGAGCTGGCCGAGGTCGAGGCCGGCACGCGCTCGGCGAGTGCCTGCGCCGGCCGCCTGTTCACACTGCTGCGCCGGGCGCCGTTCGTGCCGCCGGTCTACCGGTTCGCCGATCCGGACGCCCGCTACTACCACTTCTCCACGGCGCGACGGCTGCGCATGCTGTTGTGGTCGAAGACCGTGGCGCCCGCCGAGTTCCGGACGATGATGACCAAGGAGAACCTCACCAACGTGCCGCCTCCCGCGATGCACTGA	MTVETPSTPFDVAVLGTHLGCAMLAAILAKQGVRVLLVDAAPGQEEFAGETTVPYTAEVFFTLARRFDIPELAAFGLTSALPSEIRRSSGIKRSLGFLHHSEGRQQVPEQAVQFNVPGEHAEWHLYRPHVDQHAWTIARRYGAVVVPHRPAVADVRVGAGGADVLLADGSLHRARFVVDGSGAGSPLVRRLGAEDAAPKLRSRSRVLATHMYGVRPYEQCVRQADYVSATDWSMGTISHLFPGGWLQLAHFGNGEDPVNPLTSVVLSLDPGRYADLPGDPEQAFRELVRRFPTLARSFKDAVAARPWTAARVWQRTAGPAFGEGWFLFDRTFSRNDLFLSRDVTMTAEMVHALAPALVEAARRDDWSTPALRRAALFQERLVDFNDRLLAGARTATTDFRLWNAYSRVWLLWSMLSALSLKSARNRCLARGRWEEVERFGDDAFWFRPPDGLPGLLDRALGELAEVEAGTRSASACAGRLFTLLRRAPFVPPVYRFADPDARYYHFSTARRLRMLLWSKTVAPAEFRTMMTKENLTNVPPPAMH	MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALNQKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALYESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLI	52.97	gnl|BL_ORD_ID|1179|hsp_num:0	1252		
BGC0001038.1|Pyralomicin_22 # 22350 # 24017 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGAGG;rbs_spacer=10bp;gc_cont=0.674	BGC0001038.1|Pyralomicin_22 	22350	24017	-	Loose	650	28.1054	vanD	25.47	3000005	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGAGAAACAGCAGCATGGAGAAGACCTTCTACGACGTCGCGATCCTGGGATCGGGCATCGCCGGCACGTTGCTGGGCGCGATCCTGGCCCGGCACGGCGCGAAGGTCCTCCTGGTGGACGCCGCCTCGCACCCCAGGTTCGCGGTCGGGGAGTCCACGATCCCCTACACCCTGCTCTACCTGCGCGCCCTGGCCGACCGCTACGACGTCCCGGAGATCAAGGCGCTGGCCACCTTCACGCAGACCAGGAAGACGCTCGGGGAGCGGTTCGGCGTGAAGCGGCACTTCGGGTTCCTGCTGCACCATGAGGGGCAGCCGCAGAACCCGCGCGAGACCAACGAGTTCAACACGCCGAAGAACCTGCTCAACGAGGCCGCACACTACTTCCGCCAGGACACCGACGCCTACCTGTTCCACGTCGCGATCAAGTACGGCTGCCGGGCGAGGCAGAATTTCCGGGTCGAGCAGATCGACTTCGACGACTCCGGCGTCACCGTCACCGGCCCGGACGCGCAGTACCGGGCCCGCTACCTGGTGGACGCCAGCGGCTTCCGTTCCCCGGTGGCGGACAAGTTCGGCCTGCGGGAGAACCCGTGCCGGCTCAAGCACCATTCGCGCTCGGTCTGGAACCACATGCTCGACGTCACTCCGACCGACGACCTGTTCCGGCACGGCAAGGAGAACCGGCCGCCGTTCCCCTGGTACGAGGGCACCGTCCACCACATGTTCGAGCGTGGCTGGGCGTGGGTGATCGCCTTCGACAACAACAAGTGGTCGACCAACCCGCTGTGCAGCGTGGGCATGACCGTCGACCCCCGGACCTACCCCAAGCCCGAGCACCTGACCCCCGAGGAGGACTTCTACGCGCTCGCCGCGCCCTACCCCGACATCGCCCGGCAGTTCGAGGGGGCCAAGGCTGTACGCGAGTGGGTGTCCACGCCGCGGCTGCAGTACTCCTCCAGCCGCTGCGCCGGCGACCGCTGGTTCCTGCTCTCGCACGCGGCCGGCTTCATCGACCCGCTGTTCTCCCGCGGCCTGTCGAACACCGCCGAGGCGGTGCACGCCCTGGCCTGGCGGCTGCTGGCCGCGATCAAGGAGGACGACTTCTCCGCCGAGCGCTTCGCGTTTGTCGAGCGCCTGCAGCAGAAGCTGTTCGACTACAACGACTCGCTGGTCAACGCCGCCTTCATCTCCTGGCGCGAGTACGACCTGTGGACCGCGGTGTTCCGCTTCTGGGCCTGGGGCGCGAACGCCGGCTGCTACCAGATCCAGCGTGCGCTCAGCCGGTTCGCGCAGGACGGCGACGACAAGCACTTCAGGGAACTGGAGAAGGCGCCGCACCTTGGGCACTACTGGGGCTTCAACGACGGCTTCGCCAAGGCCTACGACAGCATGGTCGAACAGGTGGACGCGGTCGAGGCCGGCCACCTCAGCCCGCGCGAGGCGGCCGACGACCTGTACAACCAGATGCACCATGCCGACTTCTGGCCCAAGCACTTCGGCTTCGCCGAGCGGGACGTGCGTTTCATCAGCCCCGGCCCCAAGACGTTCTTCAAGATGGCGCGCTGGGCGAAGACCGAGGCCGACCCCGAGCTGGGCACGCTCATGATCGAGACCGGGAAGGCGGCGTTGAAGTCCCGCTTCCTCAAGGGACGCAAGCTGTTCTGA	MRNSSMEKTFYDVAILGSGIAGTLLGAILARHGAKVLLVDAASHPRFAVGESTIPYTLLYLRALADRYDVPEIKALATFTQTRKTLGERFGVKRHFGFLLHHEGQPQNPRETNEFNTPKNLLNEAAHYFRQDTDAYLFHVAIKYGCRARQNFRVEQIDFDDSGVTVTGPDAQYRARYLVDASGFRSPVADKFGLRENPCRLKHHSRSVWNHMLDVTPTDDLFRHGKENRPPFPWYEGTVHHMFERGWAWVIAFDNNKWSTNPLCSVGMTVDPRTYPKPEHLTPEEDFYALAAPYPDIARQFEGAKAVREWVSTPRLQYSSSRCAGDRWFLLSHAAGFIDPLFSRGLSNTAEAVHALAWRLLAAIKEDDFSAERFAFVERLQQKLFDYNDSLVNAAFISWREYDLWTAVFRFWAWGANAGCYQIQRALSRFAQDGDDKHFRELEKAPHLGHYWGFNDGFAKAYDSMVEQVDAVEAGHLSPREAADDLYNQMHHADFWPKHFGFAERDVRFISPGPKTFFKMARWAKTEADPELGTLMIETGKAALKSRFLKGRKLF	MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWENYAGYPAVISPDRRIHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYVGCDIQSSVICMDKSLAYMVVKNAGIEVPGFRVLQKGDSLEAETLSYPVFVKPARSGSSFGVNKVCRAEELQAAVTEAGKYDSKILVEEAVSGSEVGCAILGNGNDLITGEVDQIELKHGFFKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAKKIYRVLGCRGLARIDLFLREDGSIVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIGLSLRR	161.81	gnl|BL_ORD_ID|778|hsp_num:0	824		
BGC0001038.1|Pyralomicin_23 # 24049 # 25710 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=AGTGA;rbs_spacer=6bp;gc_cont=0.700	BGC0001038.1|Pyralomicin_23 	24049	25710	-	Loose	800	29.261	Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid	40.0	3003778	protein variant model	H46P	V18A:1203	isoniazid	antibiotic target alteration	antibiotic resistant ndh	GTGACAGGGACCAGGCGCGGCAAGACGTCCGGCCAGTACGACGTGGCGATCCTGGGCAGCGGGATGGCGGGCTCGATGCTCGCCGCCGTCCTGGCCCGCAACGGGGTGGAGGTGCTGCTGGTCGATCAGGGCACCCATCCGCGATTCGCGGTGGGGGAGTCGACCATTCCCTACACCTCCGCCATGACGCGGATCATCGCCGACCGCTACCGCGTGCCGGAGATCGGGGCGTTAGCCAGCTTCAAAGGCATACAACGTCATATTTCGCGAAATTCCGGTATTAAGCAGAACTTTGGGTTCGTCTACCACCGCGAAGGGCGCCCGCAGAACCCGGAGGAGATCAACCAGCTCAAGATTCCCACCGCCCTGCGCACCGAGTCCCACCTCTACCGCCAGGACACCGACGCCTACCTGTTCGCCGTCGCCGTCCGCCACGGCGCCCACCCCCGGCCCGGCACCCGTATCGAGGAGGTGGACATCGACCCCGACGCCGGGGTCGAGCTGCGCGCGGCGGGCGGGGAACGCTTCCGCGCCAAGTACGTGGTGGACGCCGGCGGCTTCCGCTCGCCGCTGGCCGACCGCTTCGACCTGCGCGAGAACCCCACCCGCGCCCGCCACCACTCCCGCAGCCTGTTCACCCACATGATCGGGGTGCGCCCGTTCGACGCGGCCCCGGCGGCAGCGCTGCACCGCCAGCCCAGCCCCTGGCACAACGGCACGCTCCACCACGTCTTCGACGGCGGCTGGCTCTGGGTCATCCCCTTCGACAACCACCCCGGCTCGACCAACCCGCTGTGCAGCGTGGGGCTCACGCTCGACCCCCGGCGCTTCCCCCAGGAGGAGCCGGACCCCCAGCGGGAGTTCGACGGCTTCCTCAAGCGCTTCCCCGAGATCGCCTGGCAGTTCACCGACGCCGTCGCCACCCGCCCGTGGGTGTCGACCGGCCGGCTGCAGTACTCCGCCAAGCGCCTGGTCGGCGACCGCTTCTGCCTCACCTCGCACGCGGCCGGCTTCATCGACGCCCTGTACTCGCGCGGGCTCACCAACACCCTGGACGTGGTCAACGCCCTGGCCTGGCGGCTGATCGCGGCCGCCCGCGAGGACGACTGGTCCACCGAGCGCTTCTCCTACGTCGAGACGCTGCAGCAGGGCCTCTTCGACGTCCATGACGACCTGGTCTACAGCTCCTTCGTCGGGTTCAGGGACTACGAGCTGTGGAACGCCGTCTACCGCACCTGGAAGATCGGCACCGTGCTGGGCACGCTGGTCCTGGAGAACGCCCACACCGCCTTCCTGCGCACCGGCGACGACGGCCTCTTCCGCGAGCTGGAGCAGAGCGACCATCCTGGCTCCCCGTTCCCCATCAGCGACCAGTTCAACCAGTTCGGCCCCCTCACCCGCGAGCTGTGCCTGGCCGTGGAGAACGGCTCGCTGAGCCCGTCGGCCGCCGCCGCCAAGGTCTTCCACCACATCGAGGACGCCGACTACATCCCGCCGGTCTTCAACCTCGGTGACCCGGCCAACCACTTCTTCCACGCCACGCCGCCCAAGATGCTGGCCGCCGCCCGCTGGGGCAGGACCCAGGCCCCGCCGCACATCGGCGCGGTCATCCGCGGGGCCATCGCGGGCGTGGTCCGCACCCGGCTCAGCCCTCGCCACTGA	MTGTRRGKTSGQYDVAILGSGMAGSMLAAVLARNGVEVLLVDQGTHPRFAVGESTIPYTSAMTRIIADRYRVPEIGALASFKGIQRHISRNSGIKQNFGFVYHREGRPQNPEEINQLKIPTALRTESHLYRQDTDAYLFAVAVRHGAHPRPGTRIEEVDIDPDAGVELRAAGGERFRAKYVVDAGGFRSPLADRFDLRENPTRARHHSRSLFTHMIGVRPFDAAPAAALHRQPSPWHNGTLHHVFDGGWLWVIPFDNHPGSTNPLCSVGLTLDPRRFPQEEPDPQREFDGFLKRFPEIAWQFTDAVATRPWVSTGRLQYSAKRLVGDRFCLTSHAAGFIDALYSRGLTNTLDVVNALAWRLIAAAREDDWSTERFSYVETLQQGLFDVHDDLVYSSFVGFRDYELWNAVYRTWKIGTVLGTLVLENAHTAFLRTGDDGLFRELEQSDHPGSPFPISDQFNQFGPLTRELCLAVENGSLSPSAAAAKVFHHIEDADYIPPVFNLGDPANHFFHATPPKMLAAARWGRTQAPPHIGAVIRGAIAGVVRTRLSPRH	MSHPGATASDRHKVVIIGSGFGGLTAAKTLKRADVDVKLIARTTHHLFQPLLYQVATGIISEGEIAPATRVILRKQKNAQVLLCDVTHIDLENKTVDSVLLGHTYSTPYDSLIIAAGAGQSYFGNDHFAEFAPGMKSIDDALELRGRILGAFEQAERSSDPVRRAKLLTFTVVGAGPTGVEMAGQIAELADQTLRGSFRHIDPTEARVILLDAAPAVLPPMGEKLGKKARARLEKMGVEVQLGAMVTDVDRNGITVKDSDGTIRRIESACKVWSAGVSASPLGKDLAEQSGVELDRAGRVKVQPDLTLPGHPNVFVVGDMAAVEGVPGVAQGAIQGGRYAAKIIKREVSGTSPKIRTPFEYFDKGSMATVSRFSAVAKVGPVEFAGFFAWLCWLVLHLVYLVGFKTKIVTLLSWGVTFLSTKRGQLTITEQQAYARTRIEELEEIAAAVQDTEKAAS	121.01	gnl|BL_ORD_ID|2350|hsp_num:0	2287		
BGC0001038.1|Pyralomicin_24 # 25707 # 30875 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=8bp;gc_cont=0.759	BGC0001038.1|Pyralomicin_24 	25707	30875	-	Loose	750	88.1965	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	29.54	3003463	protein variant model	G387D	n/a	isoniazid	antibiotic target alteration	antibiotic resistant kasA	ATGACACAGGCCGACCTTCGCGCCCGGCTCATCGAGGCGTTGCGGGTGATCGAACAGCTGGAGGGCAGGCTCGCCGCAGGCGGGTCCGCGCCGGAGCCGATCGCCGTCGTCGGGGCGGGCTGCCGCCTGCCCGGCGGCGTCGACGGGCCCGACTCGTTCTGGAAGCTGCTGAGCGACGGAACCGACGCGGTGAGCGAGTTCCCCGCCGGCCGCGCCGACCTGGCGGCCTGGTACGACCCCGACCCCGACCGGCCCGGCACCACCTACGTGCGCCACGGCTGTTTCGTCGACCAGGTGGACCGGTTCGAGCCCGAGGTCTTCGGCATCTCCCCGCGCGAGGCCATCGGCATGGACCCCCAGCAGCGGCTCGCCCTGGAGGTCGCCTGGGAGGCCCTTGAGCACGCGGGGTACGCGCCGGACTCCCTCACCGGCAGCGCCACCGGCGTGTTCCTCGGGGTGAGCACCACCGACTACGTCCGGCTGCGGCAGGAGCGCGGCGACCCCGCCGACGTGGACGCCTACCAGCTCATGGGCGAGCCCAGCTTCACCGCCGGCCGGATCTCGTTCGTCCTCGGGCTGATGGGGCCGAGCCAGGTCGTGGACACCGCCTGCTCGTCATCCCTGGTGGCGCTGCACGACGCCTGCCAGGCGCTGCGGCTCGGCGAGTGCGACATGGCGCTGGCGGGCGGCGTCAACCTCATGCTCAGCCCGTACTCGTTCGTGCTGCTCAGCAAGTTCCGCGGGCTGGCGCCCGACGGGCGGTGCAAGACCTTCGACGCCGCCGCCGACGGGTACGGGCGCGGCGAGGGCGCCGGCATCGTGGTGCTCAAGCGGCTCTCCGACGCAGAGCGGGACCGTGACCACGTGCTGGCGGTCATCCGCGGCACCGCCGTCGCGCACGACGGGCGCAGCAGCGGCATGACGGTGCCCAATCCGGCCTCCCAGCAGGCCGTCATCAGGGACGCGCTCAAGCAGGCCGGCCTGACCCCGGCCGACATCGACTACGTGGAGGCCCACGGCACGGGAACCGCGCTCGGCGACCCGATCGAGCTGCGCGCGCTGCAGGCGGTCATCGGGCAGGCGCACAGCCGCGCCGCCCCGCTCCTGGTCGGCTCGGTCAAGACGAACATCGGCCACCTGGAGGCCGCCGCGGGCGTCGCCGGGCTGCTCAAGGTGGTGCTGTCCCTGCACCACCGGGAGATCCCGCCGCATCTGCACTTCACCGACCCCAACCCGAACGTGGACTGGTCAGGGCTGCACGTCCGCGTCGCCGACGAGAGACGGCCGTGGCCGGTGCGCGGCGGCGTGCGCGCGGGCGGGATCAGCAGCTTCGGCGCCAGCGGGACCAACGCCCACGCCGTGGTCACCGAGCCGCCGCCGCGTCCGGTGCCCGCCCAGGCGCCCGGGCCGCGGCGCGAGCACGGCGTGCTGACGCTGTCGGCGCGCACCGAGGGCAGCCTGCGCGAGCTGGCCAAGGCGTACGCCTCCTGGCTCAGGACGCCGGGCACCGGGTCGATCGAGGACGTCTGCCGCACCAGCCAGAGCGGGCGCGGCAGGATGGCCAAGGGGCTGGCCGTCGTCGGCGACTCGTCCGCGGAGCTGGCGCGGGCGCTGGAGACGTTCGGCCGCGGCGAGCACGACGACGGCTGGACGGGCGTCGCGCTCGCGCCGCACCGCAACCGCGGTCTGGCCTGGCTGTTCACCGGCCAGGGCGCGCAGTACGGGCGCATGGGCGAGGATCTGCGCGCCGAGCCGGCCTACCGGGAGGCGATCGAGCGCGTCGCCGAGCTGATGGACCCGCTGCTCGACCAGCCGTTGGCCGCGCTGCTCGACCTGCCGGACGACGCGGGCTCCCCGATCCACCTGACCGGCAACACCCAGCCGGCGCTGTTCGCCGTCGAGTACGCGCTGTCGCGGCTGTGGATGTCCTGGGGGGTGCGGCCCGCCGTCGTCATGGGGCACAGCGTCGGGGAGATCACCGCGGCTTGCGTGGCCGGGGTGCTCAGTCTGCCCGACGCGGTCGAGCTCGTCGCCGCCCGCGGCCGGCTCATGCAGGCCCTGCCCGCGGGTGGCGTCATGGCGACCCTGGTCTGCGACGAGGAGCGGGCGCTGCGGGCGATCCAGGGGTTCGAGGAGCTGGTCTCGGTGGCGGCGGTCAACGGCCCCGCCGACACCGTCATCGCGGGCCCGGCCCGCGAGGTCGCCCGGATCACCGACGCGCTGGCGGCCGAGGGCGTCAAGCACCGCCTGCTGAAGGTGTCCCACGCCTTCCACTCGCCGCTGCTGAAGCCGATGCTGGACGACCTGCGCGCGGTGGCCAGAGGCGTCAGGCATCACGAACCGGAGATCCGGCTGCTGTCGAACGTGACCGGCGACGAGTGGGGTGAGGAGCAGCGCGACCCGGAGTACTGGGTGCGGCACGCGCTCGCGCCGGTCCGCTTCCACGACGGGATCCGCCGGCTGCACCGCGACGGCCTGCGCACCTTCCTGGAGATCGGCCCGCAGCCGGTGCTGCTCGGCCTCGGCGCCCGGGCCCTGGACGATCCCGGCTGCCTCTGGCTGCCGTCCCTACGCAAGAACCATGACGGACGGCGGCGCACGATCGCCGCGCTGGGCGCCCTGCACCTGCGGGGCGTCGCGGTGGACTGGGCCGCCGTCCACGGGGGAGCCGGGTTCGACCGGGTGCCGCTGCCCACCCACGTGTGGGACCGGACGCGGCACTGGTTCACGGAGGTGGAGCCGGGCGCCCCGGTCATGCGCGGGCGGCCCGGCGCATCGGGCCCCGGCGTCCGGCTGCCGGTCGCGCTCCCCACCTATGAGGTCGCCGCGGACGCCGAGGCGGGGCTGGAGCGGCTGGTCGAGCTGGCCAGGCAAGCCGCGGCGGATGCGTTCGGCGGCGTTTGGCACCGGGCCGCCGCTGTGGAGCTGGCCGAGCCGGTGGCCGCCGGTCAGACCCTTCAGGTCACGGTCGAGCGGGACGGCGACGGCCCGGCCGCGTTCACCGTCAGGGGCCGCGACGACGGCGAGGCGGCGGCGTCGGCCCCCTGGCGCCTGCACGCGCGCGGCGTGCTCCACGGCGGGGCGGTCAGGGAGAGCGACGGGATCGACGGCGACGAAGACGTGGTGGTGCCGGCCGGTGAGCGTCATCCGCTGGTGGCCGCCGCCGTGGCGCTGAGCGGCGCGGAGACGGCCACGCCGGCCGGATTCGAGACACTGGCCTGGGACCCGGGCCCGCCCGTGGCGAGCGTGCGAGTACGCAGGCGGAGCGCCGAGGCCGAGTTCCGCACCGCCGGCGGCCGCGTGAGCGGCCGGGTCACCGGGCTGCGGACGGCGCAGCCGGGCGAACAGGCCGCCGCGCGCTGGCGCGACCCTGCCGAGCTGGTGTTCGAGCTGGACTGGCAGGAGGCGCCCCTGCCCGCGGCGGGCGGCCTCGACGGCGAGCGCTGGCTCCTGTTCCGCGACGGCCACGGCGTCGCCGAGCGGCTGGCCGAGCAGGTGCGCGAGCAAGGCGGACACCCGCGGCTGGTCCGCCACGCGCCCGGGGTGGGCGTGGCGGGGCTGCTCGCCGAGGGGCGGCCGCACCGGGTCGTCGTCCTCACCGGGCTCGACGCGCCCGACCTGGACGAGGCCGACGAGGACGCGCTGGTGGCCTTCCGCGACCAAGCCGAGCTGCTGGCCGTCGAGGTCGTCCAGGCGCTGCGCGACCGGCCGGGCGTCACCGTGCACCTGGTCACGCGCGGCGCGGTGCCCGCCGCCCCCGGCCGGCGGCAGCACCGGGCGGCGGCCGCCGGGCTGTGGGGGCTGGGCCGGGTGATCGCGCTGGAACATCCGGGCCTGTGGGGCGGCGCCGTGGACCTGGACCCGGCCGGACCGGCCGACGGGACCGGGCGCCTGCTTGACGCACTCGTGCACAGCGCGGAGGACCAGATCGCCCTGCGTGAGGCCCGGGCGCTGGTGTGCCGGCTGGTCCGGCGACCCTTGCCGGCCGAGCGGCTCCAGGCGGCGCCGCCCATCCGCGCCGACGGGGCCTACCTGGTCACCGGGGCGTTCGGCGGAATCGGCGTCACGGTGGCCCGATGGCTGGCCGGGCACGGCGCTCGGCGGCTGGTGCTGCTCGGCCGGACGGCGCTGCCGGAGCGGGAGCGCTGGGACGACCCTGGCCTGACGGCGGCGCAGACCGAGCGGATCGCCGTAGTGCGAGCCCTGGAGGCGCTCGGCGCCGAGGTCACCGTCGAGGCGGCGGACGTGGCCGACGCCGCCGCGGTCCGCGCGGCCGTGGCCCGCCTGGAGGCCGGCGGCGTGCCGCTGCGCGGCGTGGTCCACGCGGCCGGCGTGTCCAGACCCCAGGTTCTCGCCGAGGTGGACCGGGCGGGCTACGCGGCGGTCTGGCGGCCCAAGGTGCTGGGCGGGTGGGCGCTGCACCGCGCCACCCGGGAGTCGGAGCTGGACTTCTTTCTCGGCTTCTCCTCCATAGCTGCCGCCTGGGGCTCTCTCTACCTGGCCGGTTACGCCGCCGCCAACGCCTTTCTCGACGGCCTGGCCCAGGACCGCCGCGCGCGCGGGTTGCCCGGTCTGAGCGTGGACTGGGGGCAGTGGGAGCTGCCGTCCAAGCTGTACGGGGCGGACGTCCGCTCGTTTCTGGCCGCCAGCGGGCTGCGGGCGCTGCCCGCCGGGCAGGGGCTCCGGCTGCTGGGCGCCTTGCTGGGGGCGGACCGGGTCCAGCCGGTGGTGTGCGCGGCGGACTGGCCCGCCTACAAGGCGACGCTGGAGATCCGCGGCCCCAAGCCCGTGCTGGAGCAGGTCGAGGCGGCCCAGGCGGCCGAGGAGCCGGCGGGCGAGGCGGCACCGGTGCTGGAGGAGCTGCGCGGCTGCCCGCCGGACGAGCGGCCGGCCGTCGTCTCCGGCTACCTGCGTGACCAGCTCGCGCAGATCCTCGGCCTGGAGCGGTCGCGGCTCGACACCGAGTTCCGCCTGCTCGACCTGGGCATCGACTCGCTGATGGTGATGGAGCTGATCAGGCGGGTGCGGCGAGACCTGCGGATCGACTGCCCCGCCAAGGACTTCTTCGCCACCGACGCCGCCGAGTGGGACACGCTCCTGCTCCGGCAGGCAGCACAGCACCACGCGTTCGACATGTCCGCTACCGAGGTTGGGAGTGACGACAGGTGA	MTQADLRARLIEALRVIEQLEGRLAAGGSAPEPIAVVGAGCRLPGGVDGPDSFWKLLSDGTDAVSEFPAGRADLAAWYDPDPDRPGTTYVRHGCFVDQVDRFEPEVFGISPREAIGMDPQQRLALEVAWEALEHAGYAPDSLTGSATGVFLGVSTTDYVRLRQERGDPADVDAYQLMGEPSFTAGRISFVLGLMGPSQVVDTACSSSLVALHDACQALRLGECDMALAGGVNLMLSPYSFVLLSKFRGLAPDGRCKTFDAAADGYGRGEGAGIVVLKRLSDAERDRDHVLAVIRGTAVAHDGRSSGMTVPNPASQQAVIRDALKQAGLTPADIDYVEAHGTGTALGDPIELRALQAVIGQAHSRAAPLLVGSVKTNIGHLEAAAGVAGLLKVVLSLHHREIPPHLHFTDPNPNVDWSGLHVRVADERRPWPVRGGVRAGGISSFGASGTNAHAVVTEPPPRPVPAQAPGPRREHGVLTLSARTEGSLRELAKAYASWLRTPGTGSIEDVCRTSQSGRGRMAKGLAVVGDSSAELARALETFGRGEHDDGWTGVALAPHRNRGLAWLFTGQGAQYGRMGEDLRAEPAYREAIERVAELMDPLLDQPLAALLDLPDDAGSPIHLTGNTQPALFAVEYALSRLWMSWGVRPAVVMGHSVGEITAACVAGVLSLPDAVELVAARGRLMQALPAGGVMATLVCDEERALRAIQGFEELVSVAAVNGPADTVIAGPAREVARITDALAAEGVKHRLLKVSHAFHSPLLKPMLDDLRAVARGVRHHEPEIRLLSNVTGDEWGEEQRDPEYWVRHALAPVRFHDGIRRLHRDGLRTFLEIGPQPVLLGLGARALDDPGCLWLPSLRKNHDGRRRTIAALGALHLRGVAVDWAAVHGGAGFDRVPLPTHVWDRTRHWFTEVEPGAPVMRGRPGASGPGVRLPVALPTYEVAADAEAGLERLVELARQAAADAFGGVWHRAAAVELAEPVAAGQTLQVTVERDGDGPAAFTVRGRDDGEAAASAPWRLHARGVLHGGAVRESDGIDGDEDVVVPAGERHPLVAAAVALSGAETATPAGFETLAWDPGPPVASVRVRRRSAEAEFRTAGGRVSGRVTGLRTAQPGEQAAARWRDPAELVFELDWQEAPLPAAGGLDGERWLLFRDGHGVAERLAEQVREQGGHPRLVRHAPGVGVAGLLAEGRPHRVVVLTGLDAPDLDEADEDALVAFRDQAELLAVEVVQALRDRPGVTVHLVTRGAVPAAPGRRQHRAAAAGLWGLGRVIALEHPGLWGGAVDLDPAGPADGTGRLLDALVHSAEDQIALREARALVCRLVRRPLPAERLQAAPPIRADGAYLVTGAFGGIGVTVARWLAGHGARRLVLLGRTALPERERWDDPGLTAAQTERIAVVRALEALGAEVTVEAADVADAAAVRAAVARLEAGGVPLRGVVHAAGVSRPQVLAEVDRAGYAAVWRPKVLGGWALHRATRESELDFFLGFSSIAAAWGSLYLAGYAAANAFLDGLAQDRRARGLPGLSVDWGQWELPSKLYGADVRSFLAASGLRALPAGQGLRLLGALLGADRVQPVVCAADWPAYKATLEIRGPKPVLEQVEAAQAAEEPAGEAAPVLEELRGCPPDERPAVVSGYLRDQLAQILGLERSRLDTEFRLLDLGIDSLMVMELIRRVRRDLRIDCPAKDFFATDAAEWDTLLLRQAAQHHAFDMSATEVGSDDR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	413.94	gnl|BL_ORD_ID|2018|hsp_num:0	1943		
BGC0001038.1|Pyralomicin_25 # 30872 # 33112 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.759	BGC0001038.1|Pyralomicin_25 	30872	33112	-	Loose	600	26.1794	LMB-1	38.71	3005018	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	LMB beta-lactamase	ATGGCCACGCCGACGATCTTCCGGGCCATGTCGGCCGGCGGCGCGCTGTCCAGGGACGGCAGGTGCAAGACGTTCGACGACGCCGCCGACGGCTACGGCCGGGGCGAGGGCGCGGGTGTGGTCGTGCTGAAGCGCCTGTCCGACGCGCTGCGCGACGGCGACCGCGTGTTCGGTCTCATCCGCGGCAGCGCGGTCAACCAGGACGGCGCCAGCGGCGGACTGACCGTGCCCAGCGGTGCCGCCCAGGAGGAGGTCATCGGCGATGCGCTGCGCCAGGCGGGGCTGCGGGCCGCGGACGTCGGCTACGTCGAGGCGCACGGCACCGGAACCAGGCTCGGCGACGCCATCGAACTGCGGGCCCTGGCCGCCGCGCTCCGCCCGGAGGGCACCGCGGAACGGTCGCTGCTCGTCGGGTCGGTCAAGACCAACATCGGTCATCTGGAGGCCGCAGCCGGGGTCATCGGCCTGATCAAGGTCCTGCTCGCCTTCGACCGCGAGGTGATCCCCGCCCACCTGCACTGCGAGGTGCCGACGCGGCAGCTCGCCTGGGACCGGCTCCCGTTGCGCGTCACCACCGAGCAGGTGCCCTGGCCGAGGGCGTCCGGCACGCGTGTCGCCGGGGTGAGCGCCTTCGGGTTCACCGGTACGAATGCCCATGTCCTCGTCCAGGAGCCGCCGCCCGCCGGCGAGAGGTCCACGGCTGCCGGGACCGGCCCGGCGCTGCTGGCGGTCTCGGCCCGGACGGCGCCCGCGCTGGAGGAGGCCGTCTCGCGGCTGCGCGAGCGGCTGGCCGCCACGCCGGAGGCGGACCGCGCGGACCTGTGCTGGACCTCCGTCGCCCGGCGGATCCACCATGAGCACCGGATCGCCGTGGTGGGACGGACCGTCCGGGAGCTGGCCGAGGCGCTGGGCGCGGGGCCGCACCGCGGGCACGTGCCCGCGGGGGAGGAGCGCCCCGTCCTGTTCCACCACCGTGCCAGCCCGCCGAGCCGGCAGTGGTTCGCCGAGGTCACGCGGGAACTGCCGGGCATCGACGCGACGCGCATCCTGGAGCGCACCGAGACCGAACTACGCACCGTGGCCGCGCCGCGAACCGCCTCCGGAAACACGCCGCGAACCGCCCCCGGAAACGCGCCGGGGACAGCGCCGGGGACCGGGGCGGAGTCGCCGGCGGGAATCGAGGTGCTGGCTCGGCACGTGGCGGCCGTTCGCCTGTGGCGGGCGCTGGGCGTGGTGCCCGCCGCCGTGGCTGCGCCTCCGGATGTCGGTCCCTACCTGGCGGCCTTCGCGGCCGGTGAGCTCACCGTCGCGGAGCTGGCCCGGGCGTTCGCCGAGGGGACGCCGCCGCGCGCCGGCGGCGTCCCCTCCTTCCCCGACCTGGCCGCCGCCGCCGGGTTCGAGCTGGTGCTCGACCTCGGTGAGCACGGGTGCGCGGTCAGCCTGACCGGCGAGGCAGCCCGTCCAGGAGCCCCAACCGCCAGCGAAGCCGGCGGTGGGGTCGGGGCCGACGGCGGGGCGGAGGCGCTCGATGTGCTGGCCGCCCTGCACGTGCGGGGGGCGCGCCTTGAGTGGGGGCGGCTGGCTCCCGCCCGTCCGCGGGTGCTCTCCCTGCCCGCCTACCCGTGGCAGCGCACGCGGCACTGGGTGGAGGCCGTCGAGACGCCACCGCCGCCGGCCGCCGGGCCGCGTGCAGACGGGCCGCCCGGCAGCGGATCGGAGCCGGGGCCGCCCGTGGAGACCACGCTGCTGCGCCGCATCCGGGCCACGCCCGCGCCGGCGCGGGTGGAGGCGCTGCTGCCACCGCTGCTCGACCTGGTCGCCGAGGTGCTCGGCGGCGCCGACGACATCGATCCTGACCAGGGCTTCTTCGACATGGGCATGGACTCGGTCCTGTCGTTGCGGCTCAAGCTCGCCACCGAGGCGGCGCTCGGCATCGACCTGCCCAACACCGTCCTCTTCGAATGCCCCACCCCCCGCTCCTTCGCCCAGTTCATCGTCGCCGGCCTGGACGAGGCGCCGGCCGTGGACGGCACCGTGGACGACGCCGTGGACGACGCCGTGGACGAGCTCGCCGCGCTGAGCGACGACGCGCTCGCCGCCCGGGTCGCGGACGTGCTCGCCGGCTCCTCGGCCCGGCTGCGATCGGCCGAGGCCCCGGTCGCGGGGGTTCAAGCCATCTTTGAGCAGCCGCACGTTGACTCGGGTCACTACCCGATCTCGTCGAAGGGAAGCGACGAATGA	MATPTIFRAMSAGGALSRDGRCKTFDDAADGYGRGEGAGVVVLKRLSDALRDGDRVFGLIRGSAVNQDGASGGLTVPSGAAQEEVIGDALRQAGLRAADVGYVEAHGTGTRLGDAIELRALAAALRPEGTAERSLLVGSVKTNIGHLEAAAGVIGLIKVLLAFDREVIPAHLHCEVPTRQLAWDRLPLRVTTEQVPWPRASGTRVAGVSAFGFTGTNAHVLVQEPPPAGERSTAAGTGPALLAVSARTAPALEEAVSRLRERLAATPEADRADLCWTSVARRIHHEHRIAVVGRTVRELAEALGAGPHRGHVPAGEERPVLFHHRASPPSRQWFAEVTRELPGIDATRILERTETELRTVAAPRTASGNTPRTAPGNAPGTAPGTGAESPAGIEVLARHVAAVRLWRALGVVPAAVAAPPDVGPYLAAFAAGELTVAELARAFAEGTPPRAGGVPSFPDLAAAAGFELVLDLGEHGCAVSLTGEAARPGAPTASEAGGGVGADGGAEALDVLAALHVRGARLEWGRLAPARPRVLSLPAYPWQRTRHWVEAVETPPPPAAGPRADGPPGSGSEPGPPVETTLLRRIRATPAPARVEALLPPLLDLVAEVLGGADDIDPDQGFFDMGMDSVLSLRLKLATEAALGIDLPNTVLFECPTPRSFAQFIVAGLDEAPAVDGTVDDAVDDAVDELAALSDDALAARVADVLAGSSARLRSAEAPVAGVQAIFEQPHVDSGHYPISSKGSDE	MTLAKSFRCFCLVTTLSSMAMLAGCGGTAPVTVLSPPPADWVNSCKDWDDWDKAGPPYRIYGNSYYVGTCGISAILITGDNGHILIDGATEAGAKVIAANIDRLGFSLRDVKLLLQSHEHFDHVAGLAQLQQQSGAKLLASPAAAPVLTSGVVAAADPQAGMHEPFPAVRVDGLVTAGQVVTLGKLSLLPVATPGHTPGALSWQWSSCEAGQCQVLVYADSLSPVSSDSYRFSEHLTYLNAYRASLHKLAALDCQILLTPHPSASNMRTRLQSSAGLTDTQGCVVYADAITQRLEQRLIKETTQ	245.39	gnl|BL_ORD_ID|2810|hsp_num:0	3761		
BGC0001038.1|Pyralomicin_26 # 33112 # 36882 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGAGG;rbs_spacer=7bp;gc_cont=0.757	BGC0001038.1|Pyralomicin_26 	33112	36882	-	Loose	2000	31.187	Staphylococcus aureus mupA conferring resistance to mupirocin	29.63	3000521	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGCCCGGATACGCGACGCAGCCGAGACCCGATGACGTCGCGGTGGTCGGAGTCGGATGCCGCTTCCCCGGCGGGGTGCGGACGCCGCAGGCGTTCTGGCGCGCGCTCCGCGACGGGAAGGACGTCCTGCAGCGGGTGCCCGCCGACCGCTGGGGAAGTGGCTTCCACCACGCCGATCGCGGACGGCCGGGCGCGATCACCTCCGACCAGGGCGGTTTCCTGCCGGACATCGACAGGTTCGACGCCGCCTTCTTCGGCATCTCCCCGCGCGAGGCGGCCGAGATGGACCCGCAGCAGCGGATGCTGCTGGAGGTGACCGCCGAGGCGATGGAGGACGCCGGCGTGCCGATGCAGCGGTGGGAGGGCAGCCGGACCAGCGTCCACCTGGGAATGCTCGGCTCCGACTACCTCCTGCTGCACACCAAGACCGCAGGCGCCGCGGCGATCGGGCCGCACTTCGCCACCGGCAAGGAGTTCAGCTTCGCGGCCGGCCGGATCGCCTACGTCTTCGGCCTGCGCGGGCCGTGCATGACGGTCAACACCGCCTGCTCCTCCTCGCTGACCGCCGTCCATCTGGCCTGCCGCGCTCTGCGCGACGGTGAGGTGGACACCGCGCTGGCCGGCGGCGTCAACGCGCTGCTGACGCCCGAGCTGTCGATCTTCATGAGCAAGGTCCAGGCGTTCTCGCCGAGCGGGCGGTGCCGGCCGTTCGACGCGCGGGGCGACGGCATCGTCCGCGGCGAGGGGTGCGCGGTCGTGGTGCTCAAGCGGTACGCCGACGCGGTGCGTGACCACGACCAGATCTACGGCGTCATCCTCGGCAGTGCCGTCAACCACGACGGGCGCAGCGCGGGCCTGACCGTGCCGAGCGCGGTGGCCCAGCAGGACCTCCTGCGCGCCGCGCTGGCCTCGGCCGGCGTGGACGCCGGCGTGCCGGGCTTTGTGGAGGCGCACGGCACCGGCACGCCCCTGGGCGATCCGCTGGAACTGTCGGCCCTGGCCGCCGTCCTGGGCAGCGGCAGGGCCGCCGGGGACCGGCTGCTCGTCGGCTCGCTCAAGGCCAACTTCGGGCATCTGGACGCGACCGCGGGCGTGGCCGGCCTGCTGAAGGCCCTGCTGGTGGTCCAGCACCGCGTCGTGCCGCGGCAGATCCACTTCGACACCCCGACCCCGATGATCGACTGGGCCGACAGCGGGCTTGAGGTGCCCAAGGAGAACGTCCCGCTGCGCGGGCCCGGGGTGGCGGGCGTCAGCTCCTTCGGCCTGTCGGGGACGAACGTGCACGTCGTCGTCGGCGCGGCGAGCCCCGCCGAGCCGGCGTCGCCGTCCGCGCCCGCCGGCCCGGCGACCCTGCTGATCTCGGCCTCCACCGCCGAAGGGCTGCGCGAGCTCGCGGACGACTACCTGGACCTGCTGCGCGACGACGCCGATCTCGACGGGACGGTCGGGGCCGCCGCGGCCCGCCGTACCCACCGCGAGCACCGGCTGGCCGTCGTCGGGGCCGACGCGGCGCAGGTGCGCGGCGGGCTGACGGACTTCCGCGGCGGCGGCAAGAACAGCGCGGTGATGACCGGCGCGGCGCGGCTCGCCGAGGCCCCCGTGGTGTACGCCTTCTCCGGGCACGGCGCGCAATGGCCGAGGGCCGGCATGGACGTCTACGACGACAATGCCGTCTTCCGCGACATCCTCGACGAGTGCGACGCCGAACTACGCGCGCACAGCGGCTGGTCGGTGGTGGACGTGCTGCGCGACCCGGACCCCGCCCGGTTACAGGCGACCGCGACCGGACAACCGGCGCTGTTCGCGCTCCAGCTCGCCCTGGCCGGGCTGTGGCGCTCCTGGGGAGTGCGGCCGGCGGCGGTCGTCGGGCACAGCATGGGCGAGATCGCGGCGGCGTGCGTGGCCGGGGCGCTGTCGCTGCCGGTGGCCGCGCGGCTGATCGTCGAGCGCAGCACGGTGCTGGAGCAGGCCAAGGGGAGCGGCGCCATGGCCTCGGTCGACCTGGGCGCCGACGCCGCCCGAGAGTGGCTGGCCCGGCGCGCCCCGGAGGTGTCGGTCGCGGCGGTGAACGGCCCGCGCTCGGTCGTCGTCAGCGGCCCGGCCGAGGACGTCGCCCGGGCCGTGCGCGACTGGCAGCGGGAGAAGGTCGGGGCCGTCGCTCTGTCGGTCGAGTACCCCTCGCACGGGCCTCTGATGCGGCCCTACGGCCGGCGGCTCAGGCAGGCGACGGCCGACCTGGCCGCGTCCGCGCCGGCGATCCCCTTCCTGTCCACGGTCGATCCGGGGACGTCGGGTGGCGTGCCGGACGCCGAGTACTGGGAGCGCAACCTGTGCCGGCCCGTTCTGTTCTGGCCCGCGATCGATCGTCTGCTGGCCGAGCGTGACGCCGCGTTCGTGGAGATCGGGGCGCATCCGGTGCTGTCCCGCCCGGTCCGCGACGCGCTGGCCAGACGCGGCCGGCGCGGGATCGTGGTGGGCTCGCTGGTGCGCGGCGAGAGCGGCCCCGCGATGCTGGCCCGGTCGCGGGCACGGCTGCACGTCGCGGGCGTGGCCGTCGACTGGGCCCGGGTCTGGAACGGGCCGGTCCGCGCGGTGAGCCTGCCGCCGCCGCGCTGGGCCGACGATCGTCACTGGCTGGCGGGGGTGGAGCGGGGAACGCAGTCCGCGCCCTCTCCCGCCCTGGCGGGCCCAGGACCCGGACCGTCCGGTGTCGCCTCCGGGACGGCGCCGGTGGCCGGGCCCGAGGCCGGGCCCGAGGCGGCCTCCGGTGCCGCGTCCGGAACGGCGTCACAGGCGGCGGACGTGCGGGTCGCCGCGCACGCGTTGCTCGCGCGGGTGCTCGGCCACCCCGAAGGCACGCGCTTCCCCGAACGGCGCGGGCTGGTCGAGCTGGGACTCGACTCGGTCGGCGCGGCGGAGCTCGCCGAAGGGCTGACCCGGGTGACGGGCCGGCCGCTGGACGCCGCCGACGTACTCTCCCACGCCACCCTCGCCGCGCTGACCGAGCACCTGTCGCGATCGGCGACGCAACCGGCGACCGCCACGTCGGCACCGGAACGGGAGAGCGCCGCGGTGGCGGGACCGCGGACCGCTACGGCGAGGACCACGCCCGGCCCGTCGGGCGGCGCGTCGGGTGTCGCGTCCGGAACGGCGTCACAGGCGGCGGATGGAGCGTGGACCGGTGATGACCCCGTCGCGGTCGTCGGGTTCGCCTGCCGGGTCCCCGGCGCGCAGGACAGCGACGCCTTCTGGTCCCTGCTGAGCGACGGCCGGGACGCGACCGGACCCGTCCCGCCCGGGCGCTGGGACGCCGAGCGCCTGTTCGCCGAGGGAGCCGTCGCCACCACGCGCGGCGGCTTCCTCGACGCGGTGGACGGCTTCGACCACGGCTTCTTCCGGGTCTCGGCCCGGGAGGCGCGCAGCATGGACCCGCAGCAGCGGCTCTTCCTGGAGACCGCCTGGGAGGCACTCGAACACGCCGGCCTCACCCTGCGAGAGCTGCGCGACAGCCGCACGGGGGTGTTCGTCGGCCTCAACTCCACCGACTACCAGCAGCTCCTGCTGGGCGGCGGCGCCGAGGTCGACCTGTACTACGGGACCGGCAACTCCTTCTCCGGGGCGGCCGGGCGGCTGTCGTACCTGCTGGGGCTGCGCGGGCCGAGCCTGGCCGTCGACACCGCCTGCTCCTCCTCGCTCACCGCGGTGCACCTGGCCTGCCAGAGCCTGCGGCTGGGCGAGAGCCGGGTCGCCGTCGCGGGCGGGCGGACGTGA	MPGYATQPRPDDVAVVGVGCRFPGGVRTPQAFWRALRDGKDVLQRVPADRWGSGFHHADRGRPGAITSDQGGFLPDIDRFDAAFFGISPREAAEMDPQQRMLLEVTAEAMEDAGVPMQRWEGSRTSVHLGMLGSDYLLLHTKTAGAAAIGPHFATGKEFSFAAGRIAYVFGLRGPCMTVNTACSSSLTAVHLACRALRDGEVDTALAGGVNALLTPELSIFMSKVQAFSPSGRCRPFDARGDGIVRGEGCAVVVLKRYADAVRDHDQIYGVILGSAVNHDGRSAGLTVPSAVAQQDLLRAALASAGVDAGVPGFVEAHGTGTPLGDPLELSALAAVLGSGRAAGDRLLVGSLKANFGHLDATAGVAGLLKALLVVQHRVVPRQIHFDTPTPMIDWADSGLEVPKENVPLRGPGVAGVSSFGLSGTNVHVVVGAASPAEPASPSAPAGPATLLISASTAEGLRELADDYLDLLRDDADLDGTVGAAAARRTHREHRLAVVGADAAQVRGGLTDFRGGGKNSAVMTGAARLAEAPVVYAFSGHGAQWPRAGMDVYDDNAVFRDILDECDAELRAHSGWSVVDVLRDPDPARLQATATGQPALFALQLALAGLWRSWGVRPAAVVGHSMGEIAAACVAGALSLPVAARLIVERSTVLEQAKGSGAMASVDLGADAAREWLARRAPEVSVAAVNGPRSVVVSGPAEDVARAVRDWQREKVGAVALSVEYPSHGPLMRPYGRRLRQATADLAASAPAIPFLSTVDPGTSGGVPDAEYWERNLCRPVLFWPAIDRLLAERDAAFVEIGAHPVLSRPVRDALARRGRRGIVVGSLVRGESGPAMLARSRARLHVAGVAVDWARVWNGPVRAVSLPPPRWADDRHWLAGVERGTQSAPSPALAGPGPGPSGVASGTAPVAGPEAGPEAASGAASGTASQAADVRVAAHALLARVLGHPEGTRFPERRGLVELGLDSVGAAELAEGLTRVTGRPLDAADVLSHATLAALTEHLSRSATQPATATSAPERESAAVAGPRTATARTTPGPSGGASGVASGTASQAADGAWTGDDPVAVVGFACRVPGAQDSDAFWSLLSDGRDATGPVPPGRWDAERLFAEGAVATTRGGFLDAVDGFDHGFFRVSAREARSMDPQQRLFLETAWEALEHAGLTLRELRDSRTGVFVGLNSTDYQQLLLGGGAEVDLYYGTGNSFSGAAGRLSYLLGLRGPSLAVDTACSSSLTAVHLACQSLRLGESRVAVAGGRT	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	122.66	gnl|BL_ORD_ID|2125|hsp_num:0	2270		
BGC0001038.1|Pyralomicin_27 # 37492 # 37782 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.766	BGC0001038.1|Pyralomicin_27 	37492	37782	+	Loose	500	22.3274	vph	58.82	3003061	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	viomycin phosphotransferase	GTGGCCGGGCAGGCGGATCTGCTCCGGCTCTACCTACCCGCGATCCGCGCCGACCTGGCCATGGCGCACGAGCACCGCGGGGCTGCCGGCCCGGCGCTCGACATCCCCGTCGCGGCCTTCGGGGCCAGGGACGACGTGCTGACCGAGCCCCGCCTGCTGGCCGCGTGGGCGCGGCAGACCACCGGGCCGTTCGAGCTGACGCTGCTACCGGGGTCGCATTTCTTCCTGCACGCACCGGCCTTCGTCGCCGCCCTGCGCGGCCGGCTTGGGCGGCTGCCGGCCGCCGCGTAG	MAGQADLLRLYLPAIRADLAMAHEHRGAAGPALDIPVAAFGARDDVLTEPRLLAAWARQTTGPFELTLLPGSHFFLHAPAFVAALRGRLGRLPAAA	MRIIETHRDLLSRLLPGDTVGGLAVHEGQFHHVVIGSHRVVCFARTRAAADRLPGRADVLRALAGIDLGFRTPQPLSEGGAQGTDEPPYLVLSRIPGAPLEDDVLTSPEVAEAVARQYATLLSGLAAAGDEEKVRAALPEAPANEWQEFATGVRTELFPLMSDGGRERAERELAALDALPHLTSAVVHGDLGGENVLWETVDGVPRMSGVVDWDEVGIGDPAEDLAAIGASYGEELLGRVLALGGWADNGTAERISAIRGTFALQQALYAQRDGDEEELADGLSGYR	33.45	gnl|BL_ORD_ID|1152|hsp_num:0	1223		
BGC0001038.1|Pyralomicin_28 # 37858 # 38178 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.657	BGC0001038.1|Pyralomicin_28 	37858	38178	+	Loose	400	25.409	VIM-27	29.49	3002297	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGGCCGGCATGGAGCAGACACATCCGGACCTTCAGCGGGCGCCGGCCGGCGCCGTCGACCGCTCGCGGATCAACGCCGCGATCACCGATTACGTCAAGGTTCAGTTCCTCGACGAGGCCGAGCCGCTGTCCGAGCTCGACCAGGAGACCCCGCTGCTGGAGTGGGGGATCCTCACCAGCCTGAACACCACCATGCTGCTCAGTTTCATCCGCAGCGAGCTGGGGGTGCCCGTTCCGCTCACCCACATCACCTGGCGGAACTTCCAGAACGTGCGGGCCATCACGGACATGGTCTGCGAACTGTCCGCCCAGAACGCCTGA	MAGMEQTHPDLQRAPAGAVDRSRINAAITDYVKVQFLDEAEPLSELDQETPLLEWGILTSLNTTMLLSFIRSELGVPVPLTHITWRNFQNVRAITDMVCELSAQNA	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHISTQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE	39.85	gnl|BL_ORD_ID|994|hsp_num:0	1058		
BGC0001038.1|Pyralomicin_29 # 38210 # 39550 # 1 # ID=1_29;partial=00;start_type=GTG;rbs_motif=AGAGG;rbs_spacer=12bp;gc_cont=0.676	BGC0001038.1|Pyralomicin_29 	38210	39550	+	Loose	760	36.965	Tet(X3)	46.88	3004719	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGGACGCCGTTTTCGACATCGGCATCATCGGCGGTGGCCCGGGAGGCGCGACGGCCGCCGCGTATCTGGCCAAGGCAGGTCTTTCCGTCGCCGTCTTCGAACGCGAGACGTTCCCCCGGGAGCACGTCGGGGAGTCCCTGGTCCCCGCGACCACTCCGGTGCTGATCGAAACGGGCTGCATGGAGAAGGTCGAGCAGGCGGGATTCCCGCGCAAGTACGGCGCGGCGTGGACCTCGACCGAGCAGCGGGACATCGACCAGATGGGCTTCCGCAACCTGACCAACGGCTTCCGCTCGGCAGAGGTGCTCTTCGCCGAACGCGACCAGTTGGGGGTCGACCGCGACTACACCTTCCACGTCGACCGGGGGCTGTTCGACCAGATCCTGCTGAAGAACGCCGAGAGCCTGGGCGCGAACGTCTTCCAGGGGGTTTCGGTGGGCGAGGTCGACTTCTCCGCGGAGCTGCCGGTCATGCACGTCCGGCTCGGCCGCGTGACCACGCCCGTACCGGTGCGCATGGTGGTGGACGCCAGCGGCCGGCGCACCCACCTCGGCAACCAGCTCAGGACGAAGGTCGTCGACCCGGTCTTCAACCAGTACGCCGTGCACACCTGGTTCGACGGGCTGGACCGCGGCGCGCTGACGGTGAACAAGGAGCAGTCCGACTTCATCTTCATCCACTTCCTGCCCGTGGCCGACACCTGGGTCTGGCAGATCCCCATCACCGACACCATCACCTCGGTCGGCGTGGTGAGCCAGCGCTCGCGCCTGCGCTCCTTCGACGGCGACCGGGAGAAGTTCTTCTGGGGCACCGTCGCCAGCCACCCCGGCCTGCTCGACGTGCTGAAGAACGCCGAGCAGGTCAGGCCGCTGAAGGCCGAGGGCGACTACAGCTACGGCATGAAGCAGATCATCGGCGACCGGCACGTGCTCATCGGCGACGCGGCGCGCTTCGTCGACCCGATCTTCTCCAGCGGCGTGAGCGTGGCGCTCAACAGCGCCCGTCTGGCCTCGCAGGACATCATCGCCGCTGCCGAGGCGGGCGACTTCGGCCGGCACCGGTTCACCACCTACGAGTCCACCCTGCGCCGAGCCATGCGTAACTGGTACGAGTTCATCTCCATGTACTACCGGCTCAACATCCTGTTCACTGCCTTCGTCCAGGACGACCGCTACCGCATCGACGTGCTGAAGATGCTGCAGGGCGACGTGTACGAGGACGAGCCCGAGATCCTCGCCACGATGCGCGAGGTCGTGCGGACCGTGGAGGCGGACCCGCACCACCTCTGGCATCCCTACCTGGGTAACCTCCGGGCCCCCGCCGCGGCGCCCGGATTCTGA	MDAVFDIGIIGGGPGGATAAAYLAKAGLSVAVFERETFPREHVGESLVPATTPVLIETGCMEKVEQAGFPRKYGAAWTSTEQRDIDQMGFRNLTNGFRSAEVLFAERDQLGVDRDYTFHVDRGLFDQILLKNAESLGANVFQGVSVGEVDFSAELPVMHVRLGRVTTPVPVRMVVDASGRRTHLGNQLRTKVVDPVFNQYAVHTWFDGLDRGALTVNKEQSDFIFIHFLPVADTWVWQIPITDTITSVGVVSQRSRLRSFDGDREKFFWGTVASHPGLLDVLKNAEQVRPLKAEGDYSYGMKQIIGDRHVLIGDAARFVDPIFSSGVSVALNSARLASQDIIAAAEAGDFGRHRFTTYESTLRRAMRNWYEFISMYYRLNILFTAFVQDDRYRIDVLKMLQGDVYEDEPEILATMREVVRTVEADPHHLWHPYLGNLRAPAAAPGF	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL	114.95	gnl|BL_ORD_ID|2309|hsp_num:0	3401		
BGC0001038.1|Pyralomicin_30 # 40340 # 40471 # 1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.750	BGC0001038.1|Pyralomicin_30 	40340	40471	+	Loose	650	20.7866	otrC	33.33	3002894	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGGTGCCGGCCTGCGGGTCGGGGAAGCGGTGGCCGAAGACGGCGATCACCCGCTCGGCCCCGGTGCCGGGGAGCGCCAGTACATGATCCCGCTGTGGTCGGCGGCGGGCGTGACCGTGCGGACGTCGTAG	MGAGLRVGEAVAEDGDHPLGPGAGERQYMIPLWSAAGVTVRTS	MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAHVXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKDARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTLQIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFTISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA	12.25	gnl|BL_ORD_ID|1880|hsp_num:0	1991		
